841 biomarker pathways
Pathway ID | Term Description | Observed Gene Count | Background Gene Count | Strength | Biomarkers |
---|---|---|---|---|---|
GO:0005576 | extracellular region | 56 | 4166 | 0.59 | CEACAM6,TGFB1,EPOR,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,KLKB1,ICAM1,SEMA3A,PLA2G7,LCN9,WNT3A,ACE,ALB,PTX3,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,HBA1,AKR1B10,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TXN,THBD,EDN1,AVP,C1QTNF3,SOD3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,ENO2,FGF21,VEGFA,C19orf80 |
GO:0005615 | extracellular space | 50 | 3195 | 0.66 | CEACAM6,TGFB1,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,KLKB1,ICAM1,SEMA3A,PLA2G7,WNT3A,ACE,ALB,PTX3,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,HBA1,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,MBL2,DKK1,TXN,THBD,EDN1,AVP,C1QTNF3,SOD3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,ENO2,FGF21,VEGFA |
GO:0031982 | vesicle | 38 | 3879 | 0.46 | CEACAM6,TGFB1,HGF,MPO,APOE,CHI3L1,FABP4,SORL1,LRP6,KLKB1,ICAM1,PML,WNT3A,ACE,ALB,PTX3,LRG1,IGF1,MMP14,HBA1,APOA2,NGF,ANGPTL3,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SOD3,SPP1,INS,ITGB2,MUC16,TNF,GPI,ENO2,VEGFA |
GO:0031012 | extracellular matrix | 15 | 527 | 0.92 | TGFB1,APOE,CHI3L1,ICAM1,PTX3,TNFRSF11B,ANGPTL4,MMP14,CTGF,ANGPTL3,MBL2,SOD3,LAMA1,ADIPOQ,VEGFA |
GO:0031410 | cytoplasmic vesicle | 29 | 2386 | 0.55 | CEACAM6,TGFB1,HGF,MPO,APOE,CHI3L1,SORL1,LRP6,PML,WNT3A,ACE,ALB,PTX3,LRG1,IGF1,MMP14,HBA1,APOA2,NGF,ANGPTL3,DKK1,TLR4,EDN1,AVP,INS,ITGB2,TNF,GPI,VEGFA |
GO:0009986 | cell surface | 17 | 824 | 0.78 | CEACAM6,TGFB1,SORL1,LRP6,ICAM1,WNT3A,ACE,IL6R,CD40LG,ANGPTL3,MBL2,TLR4,THBD,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0034774 | secretory granule lumen | 11 | 324 | 1 | TGFB1,HGF,MPO,CHI3L1,ALB,PTX3,LRG1,IGF1,INS,GPI,VEGFA |
GO:0012505 | endomembrane system | 36 | 4542 | 0.36 | CEACAM6,TGFB1,HGF,MPO,APOE,CHI3L1,SORL1,LRP6,PML,WNT3A,ACE,ALB,PTX3,LRG1,IGF1,MMP14,NAGPA,CYP2D6,CTGF,APOA2,NGF,ANGPTL3,FNDC5,DKK1,TLR4,EDN1,AVP,SOD3,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,VEGFA |
GO:0005796 | Golgi lumen | 7 | 101 | 1.31 | TGFB1,WNT3A,MMP14,NGF,SOD3,INS,MUC16 |
GO:0030141 | secretory granule | 15 | 845 | 0.71 | CEACAM6,TGFB1,HGF,MPO,CHI3L1,ALB,PTX3,LRG1,IGF1,EDN1,AVP,INS,ITGB2,GPI,VEGFA |
GO:0099503 | secretory vesicle | 16 | 1010 | 0.67 | CEACAM6,TGFB1,HGF,MPO,CHI3L1,ALB,PTX3,LRG1,IGF1,NGF,EDN1,AVP,INS,ITGB2,GPI,VEGFA |
GO:0072562 | blood microparticle | 6 | 115 | 1.18 | TGFB1,APOE,ALB,ANGPTL4,HBA1,APOA2 |
GO:0005768 | endosome | 14 | 959 | 0.63 | APOE,SORL1,LRP6,PML,WNT3A,ACE,MMP14,APOA2,NGF,ANGPTL3,DKK1,TLR4,INS,TNF |
GO:0070062 | extracellular exosome | 21 | 2099 | 0.47 | MPO,APOE,CHI3L1,FABP4,SORL1,KLKB1,ICAM1,WNT3A,ACE,ALB,LRG1,HBA1,APOA2,TXN,C1QTNF3,SOD3,SPP1,ITGB2,MUC16,GPI,ENO2 |
GO:0031093 | platelet alpha granule lumen | 5 | 68 | 1.33 | TGFB1,HGF,ALB,IGF1,VEGFA |
GO:0005769 | early endosome | 9 | 375 | 0.85 | APOE,SORL1,LRP6,PML,WNT3A,APOA2,ANGPTL3,DKK1,TLR4 |
GO:0062023 | collagen-containing extracellular matrix | 9 | 396 | 0.82 | TGFB1,APOE,ICAM1,ANGPTL4,ANGPTL3,MBL2,SOD3,LAMA1,ADIPOQ |
GO:0009897 | external side of plasma membrane | 8 | 331 | 0.85 | ICAM1,ACE,IL6R,CD40LG,TLR4,THBD,ITGB2,TNF |
GO:0071682 | endocytic vesicle lumen | 3 | 20 | 1.64 | MPO,APOE,HBA1 |
GO:0005788 | endoplasmic reticulum lumen | 7 | 308 | 0.82 | APOE,WNT3A,ALB,APOA2,EDN1,SPP1,INS |
GO:0034364 | high-density lipoprotein particle | 3 | 29 | 1.48 | APOE,PLA2G7,APOA2 |
GO:1990851 | Wnt-Frizzled-LRP5/6 complex | 2 | 4 | 2.16 | LRP6,WNT3A |
GO:0005794 | Golgi apparatus | 15 | 1584 | 0.44 | TGFB1,APOE,SORL1,WNT3A,ALB,MMP14,NAGPA,CTGF,NGF,ANGPTL3,TLR4,SOD3,SPP1,INS,MUC16 |
GO:0031901 | early endosome membrane | 5 | 162 | 0.95 | SORL1,LRP6,PML,WNT3A,DKK1 |
GO:0005783 | endoplasmic reticulum | 14 | 1438 | 0.45 | APOE,CHI3L1,SORL1,LRP6,PML,WNT3A,ALB,CYP2D6,APOA2,FNDC5,EDN1,SPP1,INS,ADIPOQ |
GO:0005102 | signaling receptor binding | 38 | 1581 | 0.85 | TGFB1,HGF,CCL2,APOE,CRP,FABP4,LRP6,ICAM1,SEMA3A,WNT3A,ACE,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,APOA2,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,EDN1,AVP,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0048018 | receptor ligand activity | 24 | 490 | 1.16 | TGFB1,HGF,CCL2,SEMA3A,WNT3A,TNFRSF11B,IGF1,CXCL8,CTGF,NGF,CD40LG,ANGPTL3,FNDC5,DKK1,EDN1,AVP,SPP1,INS,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0005125 | cytokine activity | 12 | 233 | 1.18 | TGFB1,CCL2,WNT3A,TNFRSF11B,CXCL8,CD40LG,EDN1,SPP1,ADIPOQ,TNF,GPI,VEGFA |
GO:0008083 | growth factor activity | 10 | 161 | 1.26 | TGFB1,HGF,IGF1,CTGF,NGF,ANGPTL3,DKK1,GPI,FGF21,VEGFA |
GO:0005515 | protein binding | 48 | 7026 | 0.3 | CEACAM6,TGFB1,EPOR,HGF,CCL2,APOE,CRP,FABP4,SORL1,LRP6,DESI1,ICAM1,SEMA3A,PML,WNT3A,ACE,ALB,PTX3,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0005178 | integrin binding | 8 | 147 | 1.2 | ICAM1,IGF1,MMP14,CTGF,CD40LG,ANGPTL3,SPP1,ITGB2 |
GO:0098772 | molecular function regulator | 30 | 3422 | 0.41 | TGFB1,HGF,CCL2,APOE,LRP6,SEMA3A,PML,WNT3A,TNFRSF11B,ANGPTL4,IGF1,CXCL8,CTGF,APOA2,NGF,CD40LG,ANGPTL3,FNDC5,DKK1,EDN1,AVP,SPP1,INS,ADIPOQ,TNF,GPI,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0005179 | hormone activity | 7 | 124 | 1.22 | IGF1,FNDC5,EDN1,AVP,INS,ADIPOQ,C19orf80 |
GO:0042802 | identical protein binding | 21 | 1896 | 0.51 | CEACAM6,TGFB1,EPOR,HGF,APOE,CRP,LRP6,DESI1,PML,ALB,PTX3,ANGPTL4,APOA2,IL6R,TLR4,TXN,C1QTNF3,INS,ADIPOQ,TNF,VEGFA |
GO:0005488 | binding | 60 | 12516 | 0.15 | CEACAM6,TGFB1,EPOR,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,ICAM1,SEMA3A,PML,PLA2G7,LCN9,WNT3A,ACE,ALB,PTX3,TNFRSF11B,NGB,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,HBA1,CYP2D6,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SOD3,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,ENO2,FGF21,VEGFA,C19orf80 |
GO:0005126 | cytokine receptor binding | 8 | 264 | 0.95 | TGFB1,CCL2,LRG1,CXCL8,NGF,CD40LG,TNF,VEGFA |
GO:0070325 | lipoprotein particle receptor binding | 4 | 27 | 1.64 | APOE,CRP,APOA2,DKK1 |
GO:0071813 | lipoprotein particle binding | 4 | 29 | 1.61 | APOE,CRP,SORL1,APOA2 |
GO:0016209 | antioxidant activity | 5 | 74 | 1.3 | MPO,APOE,ALB,TXN,SOD3 |
GO:0044877 | protein-containing complex binding | 15 | 1216 | 0.56 | HGF,APOE,CRP,SORL1,ICAM1,PTX3,IGF1,MMP14,CTGF,APOA2,CD40LG,ANGPTL3,SPP1,INS,ITGB2 |
GO:0001846 | opsonin binding | 3 | 15 | 1.77 | CRP,PTX3,ITGB2 |
GO:0008201 | heparin binding | 6 | 172 | 1.01 | MPO,APOE,CTGF,ANGPTL3,SOD3,VEGFA |
GO:0001664 | G protein-coupled receptor binding | 7 | 294 | 0.84 | CCL2,LRP6,WNT3A,ACE,CXCL8,EDN1,AVP |
GO:0001848 | complement binding | 3 | 21 | 1.62 | CRP,PTX3,ITGB2 |
GO:0050750 | low-density lipoprotein particle receptor binding | 3 | 22 | 1.6 | APOE,CRP,DKK1 |
GO:0001540 | amyloid-beta binding | 4 | 76 | 1.19 | APOE,SORL1,TLR4,ITGB2 |
GO:0038191 | neuropilin binding | 2 | 5 | 2.07 | SEMA3A,VEGFA |
hsa05144 | Malaria | 9 | 46 | 1.76 | TGFB1,HGF,CCL2,ICAM1,CXCL8,CD40LG,TLR4,ITGB2,TNF |
hsa05323 | Rheumatoid arthritis | 8 | 85 | 1.44 | TGFB1,CCL2,ICAM1,CXCL8,TLR4,ITGB2,TNF,VEGFA |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 8 | 98 | 1.38 | TGFB1,CCL2,ICAM1,CXCL8,THBD,EDN1,TNF,VEGFA |
hsa04979 | Cholesterol metabolism | 6 | 48 | 1.56 | APOE,ENSG00000224916,ANGPTL4,APOA2,ANGPTL3,C19orf80 |
hsa05200 | Pathways in cancer | 13 | 517 | 0.87 | TGFB1,EPOR,HGF,LRP6,PML,WNT3A,IGF1,CXCL8,IL6R,EDN1,LAMA1,FGF21,VEGFA |
hsa04151 | PI3K-Akt signaling pathway | 11 | 350 | 0.96 | EPOR,HGF,IGF1,IL6R,NGF,TLR4,LAMA1,SPP1,INS,FGF21,VEGFA |
hsa04066 | HIF-1 signaling pathway | 7 | 106 | 1.29 | IGF1,IL6R,TLR4,EDN1,INS,ENO2,VEGFA |
hsa05418 | Fluid shear stress and atherosclerosis | 7 | 130 | 1.2 | CCL2,ICAM1,TXN,THBD,EDN1,TNF,VEGFA |
hsa04060 | Cytokine-cytokine receptor interaction | 9 | 282 | 0.97 | TGFB1,EPOR,CCL2,TNFRSF11B,CXCL8,IL6R,NGF,CD40LG,TNF |
hsa05410 | Hypertrophic cardiomyopathy | 6 | 89 | 1.29 | TGFB1,ACE,IGF1,EDN1,LAMA1,TNF |
hsa05142 | Chagas disease | 6 | 99 | 1.25 | TGFB1,CCL2,ACE,CXCL8,TLR4,TNF |
hsa05146 | Amoebiasis | 6 | 100 | 1.24 | TGFB1,CXCL8,TLR4,LAMA1,ITGB2,TNF |
hsa05205 | Proteoglycans in cancer | 7 | 196 | 1.02 | TGFB1,HGF,WNT3A,IGF1,TLR4,TNF,VEGFA |
hsa03320 | PPAR signaling pathway | 5 | 75 | 1.29 | FABP4,UCP1,ANGPTL4,APOA2,ADIPOQ |
hsa04010 | MAPK signaling pathway | 8 | 288 | 0.91 | TGFB1,HGF,IGF1,NGF,INS,TNF,FGF21,VEGFA |
hsa04015 | Rap1 signaling pathway | 7 | 202 | 1.01 | HGF,IGF1,NGF,INS,ITGB2,FGF21,VEGFA |
hsa04932 | Non-alcoholic fatty liver disease | 6 | 148 | 1.07 | TGFB1,CXCL8,IL6R,INS,ADIPOQ,TNF |
hsa05164 | Influenza A | 6 | 165 | 1.03 | CCL2,ICAM1,PML,CXCL8,TLR4,TNF |
hsa04064 | NF-kappa B signaling pathway | 5 | 101 | 1.16 | ICAM1,CXCL8,CD40LG,TLR4,TNF |
hsa05145 | Toxoplasmosis | 5 | 105 | 1.14 | TGFB1,CD40LG,TLR4,LAMA1,TNF |
hsa04668 | TNF signaling pathway | 5 | 112 | 1.12 | CCL2,ICAM1,MMP14,EDN1,TNF |
hsa05134 | Legionellosis | 4 | 55 | 1.33 | CXCL8,TLR4,ITGB2,TNF |
hsa05416 | Viral myocarditis | 4 | 55 | 1.33 | ICAM1,CD40LG,LAMA1,ITGB2 |
hsa05140 | Leishmaniasis | 4 | 70 | 1.22 | TGFB1,TLR4,ITGB2,TNF |
hsa04014 | Ras signaling pathway | 6 | 226 | 0.89 | HGF,IGF1,NGF,INS,FGF21,VEGFA |
hsa05133 | Pertussis | 4 | 74 | 1.2 | CXCL8,TLR4,ITGB2,TNF |
hsa05226 | Gastric cancer | 5 | 144 | 1.01 | TGFB1,HGF,LRP6,WNT3A,FGF21 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 4 | 78 | 1.18 | HGF,IGF1,IL6R,VEGFA |
hsa04150 | mTOR signaling pathway | 5 | 151 | 0.99 | LRP6,WNT3A,IGF1,INS,TNF |
hsa04610 | Complement and coagulation cascades | 4 | 82 | 1.15 | KLKB1,MBL2,THBD,ITGB2 |
hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4 | 96 | 1.09 | CCL2,CXCL8,IL6R,TNF |
hsa04621 | NOD-like receptor signaling pathway | 5 | 174 | 0.92 | CCL2,CXCL8,TLR4,TXN,TNF |
hsa05414 | Dilated cardiomyopathy | 4 | 95 | 1.09 | TGFB1,IGF1,LAMA1,TNF |
hsa04620 | Toll-like receptor signaling pathway | 4 | 101 | 1.06 | CXCL8,TLR4,SPP1,TNF |
hsa04510 | Focal adhesion | 5 | 198 | 0.87 | HGF,IGF1,LAMA1,SPP1,VEGFA |
hsa04930 | Type II diabetes mellitus | 3 | 46 | 1.28 | INS,ADIPOQ,TNF |
hsa05135 | Yersinia infection | 4 | 125 | 0.97 | CCL2,CXCL8,TLR4,TNF |
hsa05163 | Human cytomegalovirus infection | 5 | 218 | 0.83 | CCL2,CXCL8,IL6R,TNF,VEGFA |
hsa05321 | Inflammatory bowel disease | 3 | 60 | 1.16 | TGFB1,TLR4,TNF |
hsa05010 | Alzheimer disease | 6 | 355 | 0.69 | APOE,LRP6,WNT3A,DKK1,INS,TNF |
hsa04145 | Phagosome | 4 | 142 | 0.92 | MPO,MBL2,TLR4,ITGB2 |
hsa05211 | Renal cell carcinoma | 3 | 66 | 1.12 | TGFB1,HGF,VEGFA |
hsa05224 | Breast cancer | 4 | 145 | 0.91 | LRP6,WNT3A,IGF1,FGF21 |
hsa04390 | Hippo signaling pathway | 4 | 153 | 0.88 | TGFB1,WNT3A,CTGF,ITGB2 |
hsa05218 | Melanoma | 3 | 72 | 1.09 | HGF,IGF1,FGF21 |
hsa05161 | Hepatitis B | 4 | 159 | 0.87 | TGFB1,CXCL8,TLR4,TNF |
hsa05225 | Hepatocellular carcinoma | 4 | 160 | 0.86 | TGFB1,HGF,LRP6,WNT3A |
hsa05152 | Tuberculosis | 4 | 168 | 0.84 | TGFB1,TLR4,ITGB2,TNF |
hsa05202 | Transcriptional misregulation in cancer | 4 | 171 | 0.83 | MPO,PML,IGF1,CXCL8 |
hsa05150 | Staphylococcus aureus infection | 3 | 86 | 1.01 | ICAM1,MBL2,ITGB2 |
hsa04211 | Longevity regulating pathway | 3 | 87 | 1 | IGF1,INS,ADIPOQ |
hsa04640 | Hematopoietic cell lineage | 3 | 91 | 0.98 | EPOR,IL6R,TNF |
hsa04657 | IL-17 signaling pathway | 3 | 92 | 0.98 | CCL2,CXCL8,TNF |
hsa05310 | Asthma | 2 | 27 | 1.34 | CD40LG,TNF |
hsa05165 | Human papillomavirus infection | 5 | 325 | 0.65 | WNT3A,LAMA1,SPP1,TNF,VEGFA |
hsa05132 | Salmonella infection | 4 | 209 | 0.75 | CXCL8,TLR4,TXN,TNF |
hsa05166 | Human T-cell leukemia virus 1 infection | 4 | 211 | 0.74 | TGFB1,ICAM1,ITGB2,TNF |
GO:0051240 | positive regulation of multicellular organismal process | 37 | 1770 | 0.79 | TGFB1,HGF,APOE,CHI3L1,FABP4,MTNR1B,SORL1,UCP1,ICAM1,SEMA3A,PML,WNT3A,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA |
GO:0051239 | regulation of multicellular organismal process | 43 | 3227 | 0.59 | TGFB1,HGF,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,THBD,EDN1,AVP,C1QTNF3,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA |
GO:0032879 | regulation of localization | 38 | 2740 | 0.61 | CEACAM6,TGFB1,HGF,CCL2,APOE,CRP,MTNR1B,SORL1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,ACE,PTX3,IGF1,CXCL8,MMP14,APOA2,IL6R,CD40LG,ANGPTL3,MBL2,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA |
GO:0048584 | positive regulation of response to stimulus | 35 | 2257 | 0.66 | TGFB1,EPOR,HGF,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,LRG1,IGF1,CXCL8,CTGF,IL6R,NGF,CD40LG,MBL2,DKK1,TLR4,TXN,THBD,EDN1,INS,ITGB2,MUC16,ADIPOQ,TNF,FGF21,VEGFA |
GO:0001932 | regulation of protein phosphorylation | 29 | 1459 | 0.76 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,ACE,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:0048518 | positive regulation of biological process | 53 | 6112 | 0.4 | CEACAM6,TGFB1,EPOR,HGF,CCL2,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,ACE,PTX3,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,HBA1,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0060548 | negative regulation of cell death | 25 | 999 | 0.86 | CEACAM6,HGF,MPO,CCL2,APOE,MTNR1B,SORL1,LRP6,ICAM1,WNT3A,ALB,ANGPTL4,IGF1,CTGF,NGF,CD40LG,DKK1,TXN,EDN1,AVP,INS,TNF,TNFAIP8,FGF21,VEGFA |
GO:0010941 | regulation of cell death | 30 | 1696 | 0.71 | CEACAM6,HGF,MPO,CCL2,APOE,MTNR1B,SORL1,LRP6,ICAM1,PML,WNT3A,ALB,ANGPTL4,IGF1,HBA1,CTGF,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA |
GO:0001934 | positive regulation of protein phosphorylation | 24 | 1019 | 0.84 | TGFB1,HGF,CCL2,APOE,CHI3L1,ICAM1,SEMA3A,WNT3A,ACE,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0065008 | regulation of biological quality | 43 | 4042 | 0.49 | TGFB1,MPO,CCL2,APOE,CRP,FABP4,MTNR1B,SORL1,LRP6,UCP1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,ALB,TNFRSF11B,ANGPTL4,IGF1,AKR1B10,CYP2D6,CTGF,APOA2,NGF,CD40LG,ANGPTL3,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0043410 | positive regulation of MAPK cascade | 19 | 543 | 1.01 | TGFB1,HGF,CCL2,APOE,CHI3L1,ICAM1,SEMA3A,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,EDN1,INS,TNF,FGF21,VEGFA |
GO:0043408 | regulation of MAPK cascade | 21 | 725 | 0.93 | TGFB1,HGF,CCL2,APOE,CHI3L1,SORL1,ICAM1,SEMA3A,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,EDN1,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0030334 | regulation of cell migration | 22 | 865 | 0.87 | CEACAM6,TGFB1,HGF,CCL2,APOE,SORL1,ICAM1,SEMA3A,PLA2G7,ACE,IGF1,CXCL8,MMP14,IL6R,ANGPTL3,EDN1,LAMA1,INS,ADIPOQ,TNF,GPI,VEGFA |
GO:0040012 | regulation of locomotion | 23 | 969 | 0.84 | CEACAM6,TGFB1,HGF,CCL2,APOE,SORL1,ICAM1,SEMA3A,PLA2G7,WNT3A,ACE,IGF1,CXCL8,MMP14,IL6R,ANGPTL3,EDN1,LAMA1,INS,ADIPOQ,TNF,GPI,VEGFA |
GO:0051247 | positive regulation of protein metabolic process | 29 | 1715 | 0.69 | TGFB1,HGF,CCL2,APOE,CHI3L1,SORL1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,IGF1,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ADIPOQ,TNF,FGF21,VEGFA,C19orf80 |
GO:0032270 | positive regulation of cellular protein metabolic process | 28 | 1635 | 0.7 | TGFB1,HGF,CCL2,APOE,CHI3L1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,IGF1,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ADIPOQ,TNF,FGF21,VEGFA,C19orf80 |
GO:0050790 | regulation of catalytic activity | 33 | 2386 | 0.61 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,SORL1,LRP6,ICAM1,PML,WNT3A,ACE,PTX3,ANGPTL4,IGF1,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,TXN,EDN1,AVP,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,VEGFA,C19orf80 |
GO:0050896 | response to stimulus | 57 | 8046 | 0.32 | CEACAM6,TGFB1,EPOR,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ALB,PTX3,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,HBA1,AKR1B10,CYP2D6,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,SOD3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0051270 | regulation of cellular component movement | 23 | 1009 | 0.82 | CEACAM6,TGFB1,HGF,CCL2,APOE,SORL1,ICAM1,SEMA3A,PLA2G7,WNT3A,ACE,IGF1,CXCL8,MMP14,IL6R,ANGPTL3,EDN1,LAMA1,INS,ADIPOQ,TNF,GPI,VEGFA |
GO:0031401 | positive regulation of protein modification process | 25 | 1252 | 0.77 | TGFB1,HGF,CCL2,APOE,CHI3L1,ICAM1,SEMA3A,PML,WNT3A,ACE,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0042221 | response to chemical | 43 | 4333 | 0.46 | TGFB1,EPOR,HGF,MPO,CCL2,APOE,CHI3L1,FABP4,LRP6,UCP1,ICAM1,SEMA3A,PML,WNT3A,ALB,TNFRSF11B,IGF1,CXCL8,MMP14,HBA1,AKR1B10,CYP2D6,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,TXN,THBD,EDN1,AVP,SOD3,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:0048583 | regulation of response to stimulus | 42 | 4114 | 0.47 | TGFB1,EPOR,HGF,CCL2,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,LRG1,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,FGF21,VEGFA |
GO:0045859 | regulation of protein kinase activity | 21 | 812 | 0.88 | TGFB1,HGF,APOE,CHI3L1,FABP4,SORL1,LRP6,WNT3A,ACE,IGF1,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ADIPOQ,TNF,VEGFA |
GO:0010647 | positive regulation of cell communication | 29 | 1823 | 0.67 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,ICAM1,SEMA3A,PML,WNT3A,LRG1,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,C1QTNF3,SPP1,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0023056 | positive regulation of signaling | 29 | 1831 | 0.67 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,ICAM1,SEMA3A,PML,WNT3A,LRG1,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,C1QTNF3,SPP1,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0048522 | positive regulation of cellular process | 48 | 5579 | 0.4 | CEACAM6,TGFB1,EPOR,HGF,CCL2,APOE,CRP,CHI3L1,MTNR1B,SORL1,LRP6,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,ACE,PTX3,LRG1,IGF1,CXCL8,MMP14,HBA1,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0009605 | response to external stimulus | 32 | 2310 | 0.61 | TGFB1,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,UCP1,ICAM1,SEMA3A,PML,WNT3A,ALB,PTX3,TNFRSF11B,LRG1,CXCL8,MMP14,IL6R,MBL2,TLR4,THBD,EDN1,LAMA1,SPP1,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:0051246 | regulation of protein metabolic process | 35 | 2828 | 0.56 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,SORL1,LRP6,DESI1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0032268 | regulation of cellular protein metabolic process | 34 | 2693 | 0.57 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,SORL1,LRP6,DESI1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,IGF1,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0070887 | cellular response to chemical stimulus | 35 | 2919 | 0.54 | TGFB1,EPOR,HGF,MPO,CCL2,APOE,CHI3L1,FABP4,LRP6,UCP1,ICAM1,PML,WNT3A,ALB,TNFRSF11B,IGF1,CXCL8,HBA1,AKR1B10,CYP2D6,CTGF,IL6R,NGF,CD40LG,TLR4,TXN,EDN1,SOD3,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:0043066 | negative regulation of apoptotic process | 21 | 893 | 0.84 | CEACAM6,HGF,MPO,CCL2,APOE,MTNR1B,LRP6,ICAM1,ALB,ANGPTL4,IGF1,NGF,CD40LG,DKK1,EDN1,AVP,INS,TNF,TNFAIP8,FGF21,VEGFA |
GO:0006954 | inflammatory response | 17 | 515 | 0.98 | TGFB1,CCL2,CRP,CHI3L1,KLKB1,ICAM1,PTX3,CXCL8,APOA2,IL6R,CD40LG,MBL2,TLR4,SPP1,INS,ITGB2,TNF |
GO:0032101 | regulation of response to external stimulus | 22 | 1013 | 0.8 | TGFB1,HGF,CCL2,APOE,FABP4,KLKB1,SEMA3A,PML,PLA2G7,WNT3A,CXCL8,IL6R,TLR4,THBD,EDN1,C1QTNF3,SPP1,INS,MUC16,ADIPOQ,TNF,VEGFA |
GO:0051094 | positive regulation of developmental process | 25 | 1389 | 0.72 | TGFB1,HGF,APOE,CHI3L1,SORL1,SEMA3A,PML,WNT3A,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,IL6R,NGF,ANGPTL3,FNDC5,DKK1,EDN1,INS,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0051050 | positive regulation of transport | 21 | 923 | 0.82 | TGFB1,CCL2,APOE,SORL1,WNT3A,PTX3,IGF1,APOA2,MBL2,TLR4,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA |
GO:0051338 | regulation of transferase activity | 22 | 1036 | 0.79 | TGFB1,HGF,APOE,CHI3L1,FABP4,SORL1,LRP6,PML,WNT3A,ACE,IGF1,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ADIPOQ,TNF,VEGFA |
GO:0050793 | regulation of developmental process | 33 | 2648 | 0.56 | TGFB1,HGF,CCL2,APOE,CRP,CHI3L1,SORL1,ICAM1,SEMA3A,PML,WNT3A,ACE,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,IL6R,NGF,ANGPTL3,FNDC5,DKK1,TLR4,EDN1,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,VEGFA |
GO:1902533 | positive regulation of intracellular signal transduction | 22 | 1041 | 0.79 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,ICAM1,SEMA3A,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0010033 | response to organic substance | 35 | 3011 | 0.53 | TGFB1,EPOR,HGF,MPO,CCL2,CHI3L1,FABP4,LRP6,UCP1,ICAM1,PML,WNT3A,TNFRSF11B,IGF1,CXCL8,MMP14,AKR1B10,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,THBD,EDN1,AVP,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:0048519 | negative regulation of biological process | 46 | 5389 | 0.4 | CEACAM6,TGFB1,HGF,MPO,CCL2,APOE,CRP,FABP4,MTNR1B,SORL1,LRP6,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,ALB,PTX3,TNFRSF11B,ANGPTL4,IGF1,CXCL8,MMP14,CYP2D6,CTGF,APOA2,IL6R,NGF,CD40LG,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA |
GO:1901700 | response to oxygen-containing compound | 26 | 1567 | 0.69 | TGFB1,MPO,CCL2,APOE,LRP6,UCP1,ICAM1,WNT3A,IGF1,CXCL8,HBA1,AKR1B10,CTGF,APOA2,DKK1,TLR4,TXN,THBD,EDN1,AVP,SOD3,SPP1,INS,ADIPOQ,TNF,FGF21 |
GO:0045860 | positive regulation of protein kinase activity | 17 | 550 | 0.96 | TGFB1,HGF,CHI3L1,WNT3A,ACE,IGF1,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ADIPOQ,TNF,VEGFA |
GO:0009893 | positive regulation of metabolic process | 39 | 3893 | 0.47 | TGFB1,HGF,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,UCP1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA,C19orf80 |
GO:0022603 | regulation of anatomical structure morphogenesis | 22 | 1095 | 0.77 | TGFB1,HGF,CCL2,APOE,CHI3L1,ICAM1,SEMA3A,PML,WNT3A,TNFRSF11B,ANGPTL4,LRG1,CXCL8,NGF,ANGPTL3,DKK1,EDN1,SPP1,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0043085 | positive regulation of catalytic activity | 25 | 1489 | 0.69 | TGFB1,HGF,CCL2,APOE,CHI3L1,SORL1,ICAM1,PML,WNT3A,ACE,IGF1,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0051049 | regulation of transport | 27 | 1776 | 0.65 | TGFB1,CCL2,APOE,MTNR1B,SORL1,ICAM1,PML,WNT3A,PTX3,IGF1,APOA2,CD40LG,MBL2,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,FGF21,VEGFA |
GO:0048585 | negative regulation of response to stimulus | 26 | 1636 | 0.67 | TGFB1,HGF,CCL2,APOE,MTNR1B,SORL1,LRP6,KLKB1,ICAM1,SEMA3A,WNT3A,IGF1,CXCL8,MMP14,APOA2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ADIPOQ,TNF |
GO:0051241 | negative regulation of multicellular organismal process | 23 | 1231 | 0.74 | TGFB1,HGF,APOE,MTNR1B,SORL1,KLKB1,SEMA3A,PML,WNT3A,TNFRSF11B,IGF1,APOA2,IL6R,DKK1,TLR4,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ADIPOQ,TNF |
GO:0009967 | positive regulation of signal transduction | 26 | 1654 | 0.66 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,SORL1,ICAM1,SEMA3A,PML,WNT3A,LRG1,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0002682 | regulation of immune system process | 25 | 1514 | 0.68 | TGFB1,CCL2,APOE,CRP,ICAM1,PML,PLA2G7,WNT3A,ACE,IGF1,CXCL8,MMP14,APOA2,IL6R,CD40LG,MBL2,TLR4,EDN1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,VEGFA |
GO:0042981 | regulation of apoptotic process | 25 | 1550 | 0.67 | CEACAM6,HGF,MPO,CCL2,APOE,MTNR1B,LRP6,ICAM1,PML,WNT3A,ALB,ANGPTL4,IGF1,CTGF,NGF,CD40LG,DKK1,EDN1,AVP,INS,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA |
GO:0051347 | positive regulation of transferase activity | 18 | 705 | 0.87 | TGFB1,HGF,CHI3L1,SORL1,WNT3A,ACE,IGF1,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ADIPOQ,TNF,VEGFA |
GO:0030335 | positive regulation of cell migration | 16 | 522 | 0.95 | CEACAM6,TGFB1,HGF,ICAM1,SEMA3A,PLA2G7,IGF1,CXCL8,MMP14,IL6R,ANGPTL3,EDN1,INS,TNF,GPI,VEGFA |
GO:0006950 | response to stress | 36 | 3485 | 0.48 | TGFB1,MPO,CCL2,APOE,CRP,CHI3L1,UCP1,KLKB1,ICAM1,PML,WNT3A,ALB,PTX3,ANGPTL4,IGF1,CXCL8,MMP14,HBA1,CTGF,APOA2,IL6R,CD40LG,MBL2,TLR4,TXN,THBD,EDN1,AVP,SOD3,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:2000026 | regulation of multicellular organismal development | 28 | 2096 | 0.59 | TGFB1,HGF,APOE,CHI3L1,SORL1,SEMA3A,PML,WNT3A,ACE,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,IL6R,NGF,ANGPTL3,DKK1,TLR4,EDN1,LAMA1,SPP1,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0048523 | negative regulation of cellular process | 42 | 4874 | 0.4 | CEACAM6,TGFB1,HGF,MPO,CCL2,APOE,CRP,FABP4,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,ACE,ALB,PTX3,ANGPTL4,IGF1,CXCL8,MMP14,CYP2D6,CTGF,APOA2,NGF,CD40LG,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA |
GO:1902531 | regulation of intracellular signal transduction | 26 | 1807 | 0.62 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,ICAM1,SEMA3A,PML,IGF1,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,C1QTNF3,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0065009 | regulation of molecular function | 42 | 4913 | 0.4 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,TNFRSF11B,ANGPTL4,IGF1,CXCL8,CYP2D6,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,DKK1,TLR4,TXN,EDN1,AVP,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0044093 | positive regulation of molecular function | 26 | 1842 | 0.62 | TGFB1,HGF,CCL2,APOE,CHI3L1,SORL1,LRP6,ICAM1,PML,WNT3A,ACE,IGF1,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,INS,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0051716 | cellular response to stimulus | 48 | 6489 | 0.33 | CEACAM6,TGFB1,EPOR,HGF,MPO,CCL2,APOE,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,ICAM1,SEMA3A,PML,WNT3A,ALB,TNFRSF11B,IGF1,CXCL8,HBA1,AKR1B10,CYP2D6,MOK,CTGF,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,DKK1,TLR4,TXN,EDN1,AVP,SOD3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0043405 | regulation of MAP kinase activity | 13 | 342 | 1.05 | TGFB1,HGF,APOE,SORL1,IGF1,NGF,CD40LG,DKK1,TLR4,EDN1,ADIPOQ,TNF,VEGFA |
GO:0044092 | negative regulation of molecular function | 21 | 1163 | 0.72 | HGF,APOE,FABP4,MTNR1B,SORL1,LRP6,PML,ACE,PTX3,ANGPTL4,CYP2D6,APOA2,NGF,ANGPTL3,DKK1,AVP,INS,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:0002684 | positive regulation of immune system process | 19 | 949 | 0.77 | TGFB1,CCL2,CRP,ICAM1,PLA2G7,WNT3A,IGF1,CXCL8,MMP14,IL6R,CD40LG,MBL2,TLR4,EDN1,ITGB2,MUC16,TNF,GPI,VEGFA |
GO:0050794 | regulation of cellular process | 61 | 10932 | 0.21 | CEACAM6,TGFB1,EPOR,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,ACE,ALB,PTX3,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,HBA1,CYP2D6,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,TNFAIP8,ENO2,FGF21,VEGFA,C19orf80 |
GO:0051179 | localization | 44 | 5591 | 0.36 | CEACAM6,TGFB1,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,ICAM1,SEMA3A,PML,WNT3A,ACE,ALB,PTX3,NGB,LRG1,IGF1,CXCL8,MMP14,NAGPA,HBA1,CTGF,APOA2,IL6R,CD40LG,ANGPTL3,MBL2,TLR4,TXN,THBD,EDN1,AVP,INS,ITGB2,ADIPOQ,TNF,GPI,VEGFA |
GO:1903530 | regulation of secretion by cell | 16 | 630 | 0.87 | TGFB1,APOE,MTNR1B,SORL1,IGF1,CD40LG,TLR4,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,GPI |
GO:0032102 | negative regulation of response to external stimulus | 13 | 367 | 1.01 | HGF,CCL2,APOE,KLKB1,SEMA3A,WNT3A,THBD,EDN1,C1QTNF3,SPP1,INS,ADIPOQ,TNF |
GO:0042127 | regulation of cell population proliferation | 24 | 1642 | 0.63 | CEACAM6,TGFB1,CCL2,APOE,CRP,LRP6,PML,WNT3A,ACE,LRG1,IGF1,CXCL8,CTGF,IL6R,NGF,CD40LG,TLR4,EDN1,AVP,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0033993 | response to lipid | 18 | 858 | 0.79 | TGFB1,MPO,CCL2,LRP6,UCP1,ICAM1,WNT3A,CXCL8,CTGF,APOA2,DKK1,TLR4,THBD,EDN1,AVP,SPP1,ADIPOQ,TNF |
GO:0031325 | positive regulation of cellular metabolic process | 34 | 3413 | 0.46 | TGFB1,HGF,CCL2,APOE,CRP,CHI3L1,LRP6,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA,C19orf80 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 33 | 3239 | 0.47 | TGFB1,HGF,CCL2,APOE,CHI3L1,SORL1,LRP6,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA,C19orf80 |
GO:1903532 | positive regulation of secretion by cell | 12 | 312 | 1.05 | TGFB1,SORL1,IGF1,TLR4,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,TNF,GPI |
GO:0003018 | vascular process in circulatory system | 10 | 185 | 1.2 | TGFB1,APOE,CRP,MTNR1B,ICAM1,ACE,EDN1,AVP,INS,VEGFA |
GO:0009966 | regulation of signal transduction | 32 | 3107 | 0.48 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,LRG1,IGF1,CXCL8,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:2000377 | regulation of reactive oxygen species metabolic process | 10 | 188 | 1.19 | TGFB1,CRP,UCP1,ICAM1,PTX3,TLR4,EDN1,INS,ITGB2,TNF |
GO:0009719 | response to endogenous stimulus | 22 | 1447 | 0.65 | TGFB1,CCL2,LRP6,UCP1,ICAM1,PML,TNFRSF11B,IGF1,CXCL8,MMP14,CTGF,APOA2,NGF,ANGPTL3,TLR4,EDN1,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21 |
GO:0043086 | negative regulation of catalytic activity | 17 | 807 | 0.79 | HGF,APOE,FABP4,SORL1,LRP6,PML,PTX3,ANGPTL4,APOA2,NGF,ANGPTL3,AVP,INS,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 11 | 258 | 1.1 | TGFB1,HGF,ICAM1,WNT3A,ACE,IGF1,IL6R,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0032880 | regulation of protein localization | 18 | 934 | 0.75 | TGFB1,APOE,MTNR1B,SORL1,PML,WNT3A,IGF1,MMP14,CD40LG,TLR4,TXN,C1QTNF3,INS,ITGB2,ADIPOQ,TNF,GPI,VEGFA |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 10 | 196 | 1.17 | TGFB1,HGF,ICAM1,WNT3A,ACE,IGF1,IL6R,ADIPOQ,TNF,VEGFA |
GO:0030198 | extracellular matrix organization | 12 | 338 | 1.02 | TGFB1,KLKB1,ICAM1,WNT3A,PTX3,TNFRSF11B,MMP14,CTGF,LAMA1,SPP1,ITGB2,TNF |
GO:0051129 | negative regulation of cellular component organization | 16 | 713 | 0.82 | TGFB1,HGF,APOE,SORL1,SEMA3A,PML,WNT3A,ACE,IGF1,MMP14,APOA2,DKK1,AVP,SPP1,TNF,VEGFA |
GO:1903426 | regulation of reactive oxygen species biosynthetic process | 8 | 95 | 1.39 | UCP1,ICAM1,PTX3,TLR4,EDN1,INS,ITGB2,TNF |
GO:0001558 | regulation of cell growth | 13 | 423 | 0.95 | TGFB1,APOE,SEMA3A,PML,WNT3A,IGF1,MMP14,NGF,EDN1,AVP,SPP1,INS,VEGFA |
GO:0010604 | positive regulation of macromolecule metabolic process | 34 | 3600 | 0.44 | TGFB1,HGF,CCL2,APOE,CRP,CHI3L1,SORL1,LRP6,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,IGF1,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ADIPOQ,TNF,FGF21,VEGFA,C19orf80 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 9 | 146 | 1.26 | TGFB1,HGF,WNT3A,NGF,DKK1,TXN,AVP,TNF,VEGFA |
GO:0071900 | regulation of protein serine/threonine kinase activity | 14 | 521 | 0.89 | TGFB1,HGF,APOE,SORL1,LRP6,IGF1,NGF,CD40LG,DKK1,TLR4,EDN1,ADIPOQ,TNF,VEGFA |
GO:0051248 | negative regulation of protein metabolic process | 19 | 1096 | 0.7 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,PML,PTX3,IGF1,NGF,DKK1,TLR4,EDN1,AVP,INS,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 10 | 209 | 1.15 | TGFB1,CCL2,APOE,CHI3L1,ICAM1,CTGF,TLR4,TNF,FGF21,VEGFA |
GO:0009617 | response to bacterium | 15 | 634 | 0.84 | TGFB1,MPO,CCL2,CRP,FABP4,ICAM1,LRG1,CXCL8,IL6R,MBL2,TLR4,THBD,EDN1,ADIPOQ,TNF |
GO:0007166 | cell surface receptor signaling pathway | 27 | 2325 | 0.53 | TGFB1,EPOR,HGF,CCL2,LRP6,ICAM1,SEMA3A,PML,WNT3A,TNFRSF11B,IGF1,CXCL8,CTGF,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,EDN1,LAMA1,INS,ITGB2,MUC16,TNF,FGF21,VEGFA |
GO:0045834 | positive regulation of lipid metabolic process | 9 | 152 | 1.24 | TGFB1,APOE,APOA2,ANGPTL3,AVP,INS,ADIPOQ,TNF,FGF21 |
GO:0042592 | homeostatic process | 23 | 1676 | 0.6 | MPO,CCL2,APOE,FABP4,MTNR1B,LRP6,ICAM1,PML,ALB,ANGPTL4,CTGF,APOA2,ANGPTL3,TLR4,TXN,EDN1,AVP,C1QTNF3,INS,ADIPOQ,FGF21,VEGFA,C19orf80 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 8 | 103 | 1.36 | TGFB1,CRP,ICAM1,PTX3,TLR4,EDN1,ITGB2,TNF |
GO:0030162 | regulation of proteolysis | 16 | 747 | 0.8 | HGF,APOE,SORL1,DESI1,KLKB1,PML,WNT3A,MMP14,CTGF,NGF,AVP,INS,TNF,TNFAIP8,VEGFA,C19orf80 |
GO:0010628 | positive regulation of gene expression | 27 | 2337 | 0.53 | TGFB1,HGF,APOE,CRP,SORL1,LRP6,KLKB1,PML,WNT3A,IGF1,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,EDN1,AVP,C1QTNF3,SPP1,INS,ADIPOQ,TNF,VEGFA,C19orf80 |
GO:0071310 | cellular response to organic substance | 27 | 2369 | 0.52 | TGFB1,EPOR,HGF,CCL2,CHI3L1,FABP4,LRP6,UCP1,ICAM1,PML,WNT3A,TNFRSF11B,IGF1,CXCL8,CTGF,IL6R,NGF,CD40LG,TLR4,EDN1,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:0010646 | regulation of cell communication | 33 | 3514 | 0.44 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,LRG1,IGF1,CXCL8,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 11 | 292 | 1.04 | TGFB1,CCL2,APOE,CHI3L1,ICAM1,CTGF,TLR4,ADIPOQ,TNF,FGF21,VEGFA |
GO:0023051 | regulation of signaling | 33 | 3553 | 0.43 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,LRG1,IGF1,CXCL8,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ADIPOQ,TNF,FGF21,VEGFA |
GO:0007165 | signal transduction | 39 | 4876 | 0.37 | CEACAM6,TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,TNFRSF11B,IGF1,CXCL8,MOK,CTGF,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,DKK1,TLR4,EDN1,AVP,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0080134 | regulation of response to stress | 21 | 1437 | 0.63 | HGF,APOE,FABP4,KLKB1,SEMA3A,PML,PLA2G7,CTGF,CD40LG,DKK1,TLR4,TXN,THBD,EDN1,C1QTNF3,SPP1,INS,MUC16,ADIPOQ,TNF,VEGFA |
GO:0006952 | defense response | 20 | 1296 | 0.65 | TGFB1,MPO,CCL2,CRP,CHI3L1,KLKB1,ICAM1,PML,PTX3,CXCL8,APOA2,IL6R,CD40LG,MBL2,TLR4,EDN1,SPP1,INS,ITGB2,TNF |
GO:0002526 | acute inflammatory response | 7 | 74 | 1.44 | CRP,KLKB1,ICAM1,APOA2,IL6R,MBL2,INS |
GO:1901701 | cellular response to oxygen-containing compound | 18 | 1055 | 0.7 | TGFB1,MPO,CCL2,LRP6,UCP1,ICAM1,WNT3A,IGF1,CXCL8,AKR1B10,TLR4,EDN1,SOD3,SPP1,INS,ADIPOQ,TNF,FGF21 |
GO:1901214 | regulation of neuron death | 11 | 317 | 1.01 | CCL2,APOE,MTNR1B,SORL1,WNT3A,NGF,DKK1,TLR4,ITGB2,TNF,FGF21 |
GO:0065007 | biological regulation | 62 | 12171 | 0.17 | CEACAM6,TGFB1,EPOR,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,ACE,ALB,PTX3,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,HBA1,AKR1B10,CYP2D6,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,TNFAIP8,ENO2,FGF21,VEGFA,C19orf80 |
GO:0030155 | regulation of cell adhesion | 15 | 712 | 0.79 | CEACAM6,TGFB1,CCL2,ICAM1,PML,WNT3A,IGF1,CXCL8,MMP14,CD40LG,LAMA1,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 6 | 44 | 1.6 | ICAM1,PTX3,TLR4,EDN1,ITGB2,TNF |
GO:0050708 | regulation of protein secretion | 11 | 333 | 0.98 | TGFB1,APOE,MTNR1B,SORL1,IGF1,CD40LG,TLR4,C1QTNF3,INS,TNF,GPI |
GO:0051223 | regulation of protein transport | 14 | 617 | 0.82 | TGFB1,APOE,MTNR1B,SORL1,IGF1,CD40LG,TLR4,TXN,C1QTNF3,INS,ITGB2,ADIPOQ,TNF,GPI |
GO:0034097 | response to cytokine | 18 | 1101 | 0.68 | TGFB1,EPOR,HGF,CCL2,CHI3L1,FABP4,ICAM1,PML,TNFRSF11B,CXCL8,IL6R,CD40LG,TLR4,EDN1,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0090066 | regulation of anatomical structure size | 13 | 516 | 0.87 | APOE,CRP,MTNR1B,ICAM1,SEMA3A,WNT3A,ACE,NGF,EDN1,AVP,SPP1,INS,VEGFA |
GO:1904018 | positive regulation of vasculature development | 9 | 189 | 1.14 | HGF,CHI3L1,ANGPTL4,LRG1,CXCL8,IL6R,ANGPTL3,ITGB2,VEGFA |
GO:1901342 | regulation of vasculature development | 11 | 336 | 0.98 | HGF,CHI3L1,PML,ANGPTL4,LRG1,CXCL8,IL6R,ANGPTL3,ITGB2,TNF,VEGFA |
GO:0019216 | regulation of lipid metabolic process | 12 | 424 | 0.92 | TGFB1,APOE,SORL1,ANGPTL4,APOA2,ANGPTL3,AVP,INS,ADIPOQ,TNF,FGF21,C19orf80 |
GO:0035295 | tube development | 16 | 851 | 0.74 | TGFB1,CCL2,APOE,CHI3L1,LRP6,PML,WNT3A,ANGPTL4,CXCL8,MMP14,CTGF,ANGPTL3,EDN1,LAMA1,TNF,VEGFA |
GO:0007154 | cell communication | 40 | 5320 | 0.34 | CEACAM6,TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,ALB,TNFRSF11B,IGF1,CXCL8,MOK,CTGF,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,DKK1,TLR4,EDN1,AVP,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,FGF21,VEGFA,C19orf80 |
GO:0001817 | regulation of cytokine production | 15 | 742 | 0.77 | TGFB1,HGF,CRP,SORL1,PML,WNT3A,IGF1,APOA2,IL6R,CD40LG,TLR4,C1QTNF3,INS,ADIPOQ,TNF |
GO:0032502 | developmental process | 42 | 5841 | 0.32 | TGFB1,EPOR,HGF,MPO,CCL2,APOE,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,TNFRSF11B,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,MBL2,DKK1,TLR4,EDN1,C1QTNF3,LAMA1,SPP1,ITGB2,ADIPOQ,TNF,VEGFA,C19orf80 |
GO:0043406 | positive regulation of MAP kinase activity | 10 | 265 | 1.04 | TGFB1,HGF,IGF1,NGF,CD40LG,DKK1,TLR4,EDN1,TNF,VEGFA |
GO:0045597 | positive regulation of cell differentiation | 17 | 993 | 0.7 | TGFB1,HGF,APOE,SEMA3A,WNT3A,IGF1,MMP14,CTGF,IL6R,NGF,FNDC5,DKK1,EDN1,INS,ADIPOQ,TNF,VEGFA |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 11 | 348 | 0.97 | TGFB1,HGF,IGF1,NGF,CD40LG,DKK1,TLR4,EDN1,ADIPOQ,TNF,VEGFA |
GO:0032501 | multicellular organismal process | 46 | 6933 | 0.29 | TGFB1,EPOR,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,ACE,ALB,PTX3,TNFRSF11B,ANGPTL4,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,MBL2,DKK1,TLR4,THBD,EDN1,AVP,LAMA1,SPP1,INS,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0034612 | response to tumor necrosis factor | 10 | 269 | 1.04 | CCL2,CHI3L1,FABP4,ICAM1,TNFRSF11B,CXCL8,CD40LG,EDN1,ADIPOQ,TNF |
GO:2000351 | regulation of endothelial cell apoptotic process | 6 | 50 | 1.54 | CCL2,ICAM1,ANGPTL4,CD40LG,TNF,FGF21 |
GO:0097746 | regulation of blood vessel diameter | 8 | 139 | 1.23 | APOE,CRP,MTNR1B,ICAM1,ACE,EDN1,AVP,INS |
GO:0051091 | positive regulation of DNA-binding transcription factor activity | 10 | 271 | 1.03 | LRP6,ICAM1,WNT3A,CD40LG,TLR4,EDN1,INS,ITGB2,TNF,VEGFA |
GO:0009628 | response to abiotic stimulus | 18 | 1147 | 0.66 | MPO,CHI3L1,UCP1,ICAM1,PML,ANGPTL4,IGF1,MMP14,CTGF,TLR4,TXN,THBD,EDN1,AVP,SOD3,ADIPOQ,TNF,VEGFA |
GO:0055088 | lipid homeostasis | 8 | 142 | 1.22 | APOE,FABP4,ANGPTL4,APOA2,ANGPTL3,C1QTNF3,INS,C19orf80 |
GO:0071345 | cellular response to cytokine stimulus | 17 | 1013 | 0.69 | TGFB1,EPOR,HGF,CCL2,CHI3L1,FABP4,ICAM1,PML,TNFRSF11B,CXCL8,IL6R,CD40LG,TLR4,EDN1,ITGB2,TNF,VEGFA |
GO:0035239 | tube morphogenesis | 14 | 656 | 0.79 | TGFB1,CCL2,APOE,LRP6,PML,WNT3A,ANGPTL4,CXCL8,MMP14,CTGF,ANGPTL3,EDN1,LAMA1,VEGFA |
GO:0002687 | positive regulation of leukocyte migration | 8 | 144 | 1.21 | ICAM1,PLA2G7,CXCL8,MMP14,IL6R,EDN1,TNF,VEGFA |
GO:0001818 | negative regulation of cytokine production | 10 | 280 | 1.02 | TGFB1,HGF,PML,IGF1,APOA2,IL6R,TLR4,C1QTNF3,ADIPOQ,TNF |
GO:0002685 | regulation of leukocyte migration | 9 | 209 | 1.1 | CCL2,ICAM1,PLA2G7,CXCL8,MMP14,IL6R,EDN1,TNF,VEGFA |
GO:0001819 | positive regulation of cytokine production | 12 | 461 | 0.88 | TGFB1,HGF,SORL1,WNT3A,APOA2,IL6R,CD40LG,TLR4,C1QTNF3,INS,ADIPOQ,TNF |
GO:0032269 | negative regulation of cellular protein metabolic process | 17 | 1043 | 0.68 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,PML,NGF,DKK1,TLR4,EDN1,AVP,INS,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:0051098 | regulation of binding | 11 | 373 | 0.94 | TGFB1,APOE,SORL1,WNT3A,ACE,IGF1,CYP2D6,NGF,DKK1,TXN,ADIPOQ |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 9 | 216 | 1.09 | HGF,PML,WNT3A,CTGF,NGF,AVP,TNF,TNFAIP8,VEGFA |
GO:0008284 | positive regulation of cell population proliferation | 16 | 919 | 0.71 | CEACAM6,TGFB1,PML,WNT3A,LRG1,IGF1,CTGF,IL6R,CD40LG,TLR4,EDN1,AVP,INS,TNF,FGF21,VEGFA |
GO:0016192 | vesicle-mediated transport | 22 | 1805 | 0.55 | CEACAM6,TGFB1,HGF,MPO,APOE,CRP,CHI3L1,SORL1,LRP6,WNT3A,ALB,PTX3,LRG1,IGF1,CXCL8,HBA1,MBL2,TLR4,INS,ITGB2,GPI,VEGFA |
GO:1990748 | cellular detoxification | 7 | 101 | 1.31 | MPO,APOE,ALB,HBA1,AKR1B10,TXN,SOD3 |
GO:0030154 | cell differentiation | 32 | 3702 | 0.4 | TGFB1,HGF,CCL2,APOE,FABP4,SORL1,LRP6,UCP1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,LRG1,IGF1,MMP14,CTGF,NGF,CD40LG,MBL2,DKK1,TLR4,EDN1,C1QTNF3,LAMA1,SPP1,ITGB2,ADIPOQ,TNF,VEGFA,C19orf80 |
GO:0050920 | regulation of chemotaxis | 9 | 223 | 1.07 | TGFB1,CCL2,SEMA3A,PLA2G7,WNT3A,CXCL8,IL6R,EDN1,VEGFA |
GO:0050994 | regulation of lipid catabolic process | 6 | 60 | 1.47 | SORL1,APOA2,ANGPTL3,INS,TNF,FGF21 |
GO:0045765 | regulation of angiogenesis | 10 | 303 | 0.98 | HGF,CHI3L1,PML,ANGPTL4,LRG1,CXCL8,ANGPTL3,ITGB2,TNF,VEGFA |
GO:0032872 | regulation of stress-activated MAPK cascade | 9 | 228 | 1.06 | HGF,SEMA3A,CTGF,CD40LG,DKK1,TLR4,EDN1,TNF,VEGFA |
GO:0044057 | regulation of system process | 13 | 592 | 0.81 | HGF,APOE,MTNR1B,ICAM1,SEMA3A,ACE,IGF1,CTGF,APOA2,EDN1,AVP,C1QTNF3,ADIPOQ |
GO:0006979 | response to oxidative stress | 11 | 393 | 0.91 | MPO,APOE,UCP1,PML,MMP14,HBA1,MBL2,TXN,EDN1,SOD3,ADIPOQ |
GO:0008015 | blood circulation | 11 | 394 | 0.91 | TGFB1,APOE,CRP,MTNR1B,ICAM1,ACE,EDN1,AVP,INS,ADIPOQ,VEGFA |
GO:0034369 | plasma lipoprotein particle remodeling | 5 | 30 | 1.69 | MPO,APOE,PLA2G7,ALB,APOA2 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 8 | 164 | 1.15 | SEMA3A,CTGF,CD40LG,DKK1,TLR4,EDN1,TNF,VEGFA |
GO:0046903 | secretion | 17 | 1097 | 0.66 | CEACAM6,TGFB1,HGF,MPO,CHI3L1,ACE,ALB,PTX3,LRG1,IGF1,NAGPA,CTGF,CD40LG,EDN1,ITGB2,GPI,VEGFA |
GO:0048731 | system development | 35 | 4426 | 0.36 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,TNFRSF11B,ANGPTL4,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,MBL2,DKK1,TLR4,EDN1,LAMA1,SPP1,ADIPOQ,TNF,VEGFA |
GO:0010942 | positive regulation of cell death | 14 | 719 | 0.75 | CCL2,APOE,PML,WNT3A,HBA1,CTGF,NGF,CD40LG,DKK1,TLR4,ITGB2,ADIPOQ,TNF,TNFAIP8 |
GO:0050714 | positive regulation of protein secretion | 8 | 167 | 1.15 | TGFB1,SORL1,IGF1,TLR4,C1QTNF3,INS,TNF,GPI |
GO:0050900 | leukocyte migration | 10 | 316 | 0.97 | CEACAM6,TGFB1,CCL2,ICAM1,CXCL8,IL6R,THBD,ITGB2,TNF,VEGFA |
GO:0045766 | positive regulation of angiogenesis | 8 | 169 | 1.14 | HGF,CHI3L1,ANGPTL4,LRG1,CXCL8,ANGPTL3,ITGB2,VEGFA |
GO:0009725 | response to hormone | 15 | 849 | 0.71 | TGFB1,LRP6,UCP1,ICAM1,TNFRSF11B,MMP14,CTGF,APOA2,ANGPTL3,EDN1,SPP1,INS,ADIPOQ,TNF,FGF21 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 7 | 112 | 1.26 | TGFB1,WNT3A,NGF,TXN,AVP,TNF,VEGFA |
GO:0032940 | secretion by cell | 16 | 979 | 0.68 | CEACAM6,TGFB1,HGF,MPO,CHI3L1,ALB,PTX3,LRG1,IGF1,NAGPA,CTGF,CD40LG,EDN1,ITGB2,GPI,VEGFA |
GO:0030307 | positive regulation of cell growth | 8 | 171 | 1.14 | WNT3A,IGF1,MMP14,NGF,EDN1,AVP,INS,VEGFA |
GO:0048514 | blood vessel morphogenesis | 11 | 410 | 0.89 | TGFB1,CCL2,APOE,ANGPTL4,CXCL8,MMP14,CTGF,ANGPTL3,EDN1,LAMA1,VEGFA |
GO:0032103 | positive regulation of response to external stimulus | 12 | 511 | 0.84 | TGFB1,FABP4,KLKB1,PLA2G7,CXCL8,IL6R,TLR4,THBD,EDN1,MUC16,TNF,VEGFA |
GO:0048878 | chemical homeostasis | 17 | 1124 | 0.65 | APOE,FABP4,MTNR1B,LRP6,ICAM1,PML,ANGPTL4,APOA2,ANGPTL3,EDN1,AVP,C1QTNF3,INS,ADIPOQ,FGF21,VEGFA,C19orf80 |
GO:0071356 | cellular response to tumor necrosis factor | 9 | 245 | 1.03 | CCL2,CHI3L1,FABP4,ICAM1,TNFRSF11B,CXCL8,CD40LG,EDN1,TNF |
GO:0022407 | regulation of cell-cell adhesion | 11 | 424 | 0.88 | CEACAM6,TGFB1,CCL2,ICAM1,WNT3A,IGF1,CD40LG,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0070328 | triglyceride homeostasis | 5 | 35 | 1.62 | APOE,ANGPTL4,ANGPTL3,C1QTNF3,C19orf80 |
GO:0002443 | leukocyte mediated immunity | 13 | 641 | 0.77 | CEACAM6,MPO,CRP,CHI3L1,ICAM1,ACE,PTX3,LRG1,IL6R,CD40LG,MBL2,ITGB2,GPI |
GO:2000725 | regulation of cardiac muscle cell differentiation | 5 | 36 | 1.61 | TGFB1,WNT3A,IGF1,DKK1,EDN1 |
GO:1902947 | regulation of tau-protein kinase activity | 4 | 13 | 1.95 | HGF,APOE,SORL1,DKK1 |
GO:0002376 | immune system process | 25 | 2481 | 0.47 | CEACAM6,TGFB1,MPO,CCL2,CRP,CHI3L1,ICAM1,PML,WNT3A,ACE,PTX3,LRG1,CXCL8,IL6R,CD40LG,MBL2,TLR4,THBD,EDN1,INS,ITGB2,MUC16,TNF,GPI,VEGFA |
GO:0080090 | regulation of primary metabolic process | 41 | 6032 | 0.3 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,ANGPTL4,IGF1,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0010827 | regulation of glucose transmembrane transport | 6 | 74 | 1.37 | IGF1,EDN1,INS,ADIPOQ,TNF,FGF21 |
GO:0016477 | cell migration | 15 | 896 | 0.69 | CEACAM6,TGFB1,HGF,CCL2,ICAM1,SEMA3A,PML,CXCL8,MMP14,CTGF,IL6R,THBD,ITGB2,TNF,VEGFA |
GO:0006810 | transport | 34 | 4353 | 0.36 | CEACAM6,TGFB1,HGF,MPO,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,PML,WNT3A,ACE,ALB,PTX3,NGB,LRG1,IGF1,CXCL8,NAGPA,HBA1,CTGF,APOA2,CD40LG,MBL2,TLR4,EDN1,AVP,INS,ITGB2,GPI,VEGFA |
GO:0097006 | regulation of plasma lipoprotein particle levels | 6 | 75 | 1.37 | MPO,APOE,PLA2G7,ALB,APOA2,ADIPOQ |
GO:0032677 | regulation of interleukin-8 production | 6 | 76 | 1.36 | CRP,APOA2,IL6R,TLR4,ADIPOQ,TNF |
GO:0050727 | regulation of inflammatory response | 10 | 351 | 0.92 | HGF,APOE,FABP4,KLKB1,PLA2G7,TLR4,C1QTNF3,INS,ADIPOQ,TNF |
GO:0060627 | regulation of vesicle-mediated transport | 12 | 550 | 0.8 | CCL2,APOE,SORL1,WNT3A,PTX3,APOA2,MBL2,DKK1,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0051346 | negative regulation of hydrolase activity | 11 | 450 | 0.85 | HGF,SORL1,PTX3,ANGPTL4,APOA2,NGF,ANGPTL3,AVP,TNF,TNFAIP8,VEGFA |
GO:0010720 | positive regulation of cell development | 12 | 556 | 0.8 | TGFB1,HGF,APOE,SEMA3A,WNT3A,IGF1,NGF,DKK1,EDN1,ADIPOQ,TNF,VEGFA |
GO:0006915 | apoptotic process | 15 | 918 | 0.68 | CEACAM6,TGFB1,CHI3L1,SEMA3A,PML,TNFRSF11B,NGB,IL6R,NGF,TLR4,AVP,ITGB2,TNF,TNFAIP8,FGF21 |
GO:0034374 | low-density lipoprotein particle remodeling | 4 | 15 | 1.89 | MPO,APOE,PLA2G7,APOA2 |
GO:0019221 | cytokine-mediated signaling pathway | 13 | 678 | 0.75 | TGFB1,EPOR,HGF,CCL2,ICAM1,PML,TNFRSF11B,CXCL8,IL6R,CD40LG,ITGB2,TNF,VEGFA |
GO:0019222 | regulation of metabolic process | 44 | 6948 | 0.27 | TGFB1,HGF,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,ANGPTL4,IGF1,MMP14,CYP2D6,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0001775 | cell activation | 16 | 1075 | 0.64 | CEACAM6,MPO,CHI3L1,ICAM1,WNT3A,PTX3,LRG1,IGF1,CXCL8,CD40LG,TLR4,EDN1,INS,ITGB2,TNF,GPI |
GO:0046330 | positive regulation of JNK cascade | 7 | 137 | 1.17 | SEMA3A,CTGF,CD40LG,DKK1,TLR4,EDN1,TNF |
GO:0010648 | negative regulation of cell communication | 18 | 1382 | 0.58 | TGFB1,HGF,APOE,MTNR1B,SORL1,LRP6,ICAM1,IGF1,CXCL8,MMP14,DKK1,TLR4,EDN1,AVP,C1QTNF3,INS,ADIPOQ,TNF |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 6 | 85 | 1.31 | HGF,NGF,AVP,TNF,TNFAIP8,VEGFA |
GO:1903035 | negative regulation of response to wounding | 6 | 85 | 1.31 | APOE,KLKB1,THBD,EDN1,SPP1,TNF |
GO:0023057 | negative regulation of signaling | 18 | 1385 | 0.58 | TGFB1,HGF,APOE,MTNR1B,SORL1,LRP6,ICAM1,IGF1,CXCL8,MMP14,DKK1,TLR4,EDN1,AVP,C1QTNF3,INS,ADIPOQ,TNF |
GO:0045595 | regulation of cell differentiation | 21 | 1874 | 0.51 | TGFB1,HGF,APOE,CRP,SORL1,SEMA3A,WNT3A,IGF1,MMP14,CTGF,IL6R,NGF,FNDC5,DKK1,TLR4,EDN1,SPP1,INS,ADIPOQ,TNF,VEGFA |
GO:0032147 | activation of protein kinase activity | 10 | 376 | 0.89 | HGF,CHI3L1,IGF1,NGF,CD40LG,TLR4,TXN,INS,TNF,VEGFA |
GO:0060284 | regulation of cell development | 15 | 956 | 0.66 | TGFB1,HGF,APOE,SORL1,SEMA3A,WNT3A,IGF1,NGF,DKK1,EDN1,SPP1,INS,ADIPOQ,TNF,VEGFA |
GO:0048513 | animal organ development | 28 | 3197 | 0.41 | TGFB1,EPOR,HGF,CCL2,CHI3L1,MTNR1B,LRP6,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,CD40LG,MBL2,DKK1,EDN1,LAMA1,SPP1,ADIPOQ,TNF,VEGFA |
GO:0031323 | regulation of cellular metabolic process | 41 | 6239 | 0.28 | TGFB1,HGF,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,MMP14,CYP2D6,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0040011 | locomotion | 17 | 1251 | 0.6 | CEACAM6,TGFB1,HGF,CCL2,ICAM1,SEMA3A,PML,WNT3A,CXCL8,MMP14,CTGF,IL6R,THBD,LAMA1,ITGB2,TNF,VEGFA |
GO:0002252 | immune effector process | 15 | 969 | 0.66 | CEACAM6,MPO,CRP,CHI3L1,ICAM1,PML,ACE,PTX3,LRG1,IL6R,CD40LG,MBL2,TLR4,ITGB2,GPI |
GO:0051707 | response to other organism | 17 | 1256 | 0.6 | TGFB1,MPO,CCL2,CRP,FABP4,ICAM1,PML,PTX3,LRG1,CXCL8,IL6R,MBL2,TLR4,THBD,EDN1,ADIPOQ,TNF |
GO:0098869 | cellular oxidant detoxification | 6 | 90 | 1.29 | MPO,APOE,ALB,HBA1,TXN,SOD3 |
GO:0007275 | multicellular organism development | 36 | 5023 | 0.32 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,TNFRSF11B,ANGPTL4,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,MBL2,DKK1,TLR4,EDN1,LAMA1,SPP1,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0009968 | negative regulation of signal transduction | 17 | 1271 | 0.59 | TGFB1,HGF,APOE,MTNR1B,SORL1,LRP6,ICAM1,IGF1,CXCL8,MMP14,DKK1,TLR4,AVP,C1QTNF3,INS,ADIPOQ,TNF |
GO:0051093 | negative regulation of developmental process | 15 | 983 | 0.65 | TGFB1,APOE,CRP,SORL1,SEMA3A,PML,WNT3A,TNFRSF11B,IGF1,DKK1,TLR4,SPP1,ADIPOQ,TNF,VEGFA |
GO:0050764 | regulation of phagocytosis | 6 | 92 | 1.28 | CCL2,PTX3,APOA2,MBL2,ADIPOQ,TNF |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 4 | 19 | 1.79 | TGFB1,WNT3A,IGF1,EDN1 |
GO:0045596 | negative regulation of cell differentiation | 13 | 728 | 0.72 | TGFB1,APOE,CRP,SORL1,SEMA3A,WNT3A,IGF1,DKK1,TLR4,SPP1,ADIPOQ,TNF,VEGFA |
GO:1905952 | regulation of lipid localization | 7 | 151 | 1.13 | APOE,CRP,APOA2,EDN1,SPP1,ADIPOQ,TNF |
GO:0051336 | regulation of hydrolase activity | 17 | 1284 | 0.59 | HGF,CCL2,SORL1,ICAM1,PML,WNT3A,PTX3,ANGPTL4,CTGF,APOA2,NGF,ANGPTL3,AVP,TNF,TNFAIP8,VEGFA,C19orf80 |
GO:0080135 | regulation of cellular response to stress | 13 | 739 | 0.71 | HGF,SEMA3A,PML,CTGF,CD40LG,DKK1,TLR4,TXN,EDN1,SPP1,INS,TNF,VEGFA |
GO:0072359 | circulatory system development | 14 | 872 | 0.67 | TGFB1,EPOR,CCL2,APOE,LRP6,WNT3A,ANGPTL4,CXCL8,MMP14,CTGF,ANGPTL3,EDN1,LAMA1,VEGFA |
GO:0032496 | response to lipopolysaccharide | 9 | 313 | 0.92 | TGFB1,MPO,CCL2,ICAM1,CXCL8,TLR4,THBD,EDN1,TNF |
GO:0022612 | gland morphogenesis | 6 | 99 | 1.25 | TGFB1,LRP6,SEMA3A,PML,LAMA1,TNF |
GO:0061138 | morphogenesis of a branching epithelium | 7 | 159 | 1.11 | LRP6,SEMA3A,PML,MMP14,EDN1,LAMA1,VEGFA |
GO:0009892 | negative regulation of metabolic process | 27 | 3124 | 0.4 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,PML,ACE,PTX3,IGF1,CYP2D6,CTGF,APOA2,IL6R,NGF,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:0051235 | maintenance of location | 7 | 161 | 1.1 | APOE,SORL1,PML,ALB,ANGPTL3,TXN,TNF |
GO:0060255 | regulation of macromolecule metabolic process | 41 | 6407 | 0.27 | TGFB1,HGF,CCL2,APOE,CRP,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,MMP14,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0002697 | regulation of immune effector process | 10 | 418 | 0.84 | TGFB1,ICAM1,PML,APOA2,CD40LG,TLR4,INS,ITGB2,TNF,GPI |
GO:0010817 | regulation of hormone levels | 11 | 524 | 0.79 | MTNR1B,ACE,AKR1B10,CYP2D6,NGF,EDN1,C1QTNF3,SPP1,INS,ADIPOQ,TNF |
GO:0048856 | anatomical structure development | 37 | 5402 | 0.3 | TGFB1,EPOR,HGF,CCL2,APOE,CHI3L1,MTNR1B,SORL1,LRP6,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,TNFRSF11B,ANGPTL4,IGF1,CXCL8,MMP14,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,MBL2,DKK1,TLR4,EDN1,LAMA1,SPP1,ITGB2,ADIPOQ,TNF,VEGFA,C19orf80 |
GO:0051153 | regulation of striated muscle cell differentiation | 6 | 102 | 1.23 | TGFB1,WNT3A,IGF1,MMP14,DKK1,EDN1 |
GO:0052548 | regulation of endopeptidase activity | 10 | 418 | 0.84 | HGF,SORL1,PML,WNT3A,CTGF,NGF,AVP,TNF,TNFAIP8,VEGFA |
GO:0071396 | cellular response to lipid | 11 | 528 | 0.78 | TGFB1,CCL2,LRP6,UCP1,ICAM1,WNT3A,CXCL8,TLR4,EDN1,SPP1,TNF |
GO:0046324 | regulation of glucose import | 5 | 56 | 1.42 | IGF1,INS,ADIPOQ,TNF,FGF21 |
GO:0010721 | negative regulation of cell development | 9 | 330 | 0.9 | APOE,SORL1,SEMA3A,WNT3A,IGF1,DKK1,SPP1,TNF,VEGFA |
GO:0045444 | fat cell differentiation | 6 | 106 | 1.22 | FABP4,UCP1,LRG1,C1QTNF3,ADIPOQ,C19orf80 |
GO:1903034 | regulation of response to wounding | 7 | 169 | 1.08 | APOE,KLKB1,TLR4,THBD,EDN1,SPP1,TNF |
GO:0050995 | negative regulation of lipid catabolic process | 4 | 24 | 1.69 | SORL1,APOA2,INS,TNF |
GO:0007155 | cell adhesion | 14 | 925 | 0.65 | CEACAM6,CCL2,LRP6,ICAM1,WNT3A,ANGPTL4,CTGF,CD40LG,ANGPTL3,LAMA1,SPP1,ITGB2,MUC16,TNF |
GO:0043388 | positive regulation of DNA binding | 5 | 59 | 1.39 | TGFB1,WNT3A,IGF1,NGF,TXN |
GO:0050678 | regulation of epithelial cell proliferation | 9 | 339 | 0.89 | TGFB1,CCL2,APOE,WNT3A,LRG1,IGF1,TLR4,TNF,VEGFA |
GO:0051128 | regulation of cellular component organization | 23 | 2402 | 0.45 | TGFB1,HGF,APOE,SORL1,ICAM1,SEMA3A,PML,WNT3A,ACE,IGF1,MMP14,CTGF,APOA2,NGF,DKK1,TLR4,EDN1,AVP,SPP1,INS,TNF,ENO2,VEGFA |
GO:0051155 | positive regulation of striated muscle cell differentiation | 5 | 59 | 1.39 | TGFB1,WNT3A,IGF1,MMP14,EDN1 |
GO:0045321 | leukocyte activation | 14 | 929 | 0.64 | CEACAM6,MPO,CHI3L1,ICAM1,PTX3,LRG1,CXCL8,CD40LG,TLR4,EDN1,INS,ITGB2,TNF,GPI |
GO:0051099 | positive regulation of binding | 7 | 175 | 1.07 | TGFB1,APOE,WNT3A,ACE,IGF1,NGF,TXN |
GO:0031347 | regulation of defense response | 12 | 674 | 0.72 | HGF,APOE,FABP4,KLKB1,PML,PLA2G7,TLR4,C1QTNF3,INS,MUC16,ADIPOQ,TNF |
GO:0050867 | positive regulation of cell activation | 9 | 346 | 0.88 | TGFB1,CCL2,WNT3A,IGF1,MMP14,CTGF,CD40LG,TLR4,ITGB2 |
GO:0061387 | regulation of extent of cell growth | 6 | 113 | 1.19 | APOE,SEMA3A,WNT3A,NGF,SPP1,VEGFA |
GO:2000027 | regulation of animal organ morphogenesis | 8 | 257 | 0.96 | HGF,PML,WNT3A,TNFRSF11B,DKK1,EDN1,TNF,VEGFA |
GO:0031667 | response to nutrient levels | 10 | 449 | 0.81 | MPO,APOE,SORL1,UCP1,ICAM1,ALB,TNFRSF11B,SPP1,ADIPOQ,FGF21 |
GO:0048729 | tissue morphogenesis | 11 | 561 | 0.76 | TGFB1,LRP6,SEMA3A,PML,WNT3A,MMP14,MBL2,DKK1,EDN1,LAMA1,VEGFA |
GO:0051222 | positive regulation of protein transport | 9 | 352 | 0.87 | TGFB1,SORL1,IGF1,TLR4,C1QTNF3,INS,ITGB2,TNF,GPI |
GO:0006898 | receptor-mediated endocytosis | 7 | 184 | 1.05 | APOE,SORL1,LRP6,ALB,CXCL8,HBA1,ITGB2 |
GO:0008361 | regulation of cell size | 7 | 183 | 1.05 | APOE,SEMA3A,WNT3A,NGF,EDN1,SPP1,VEGFA |
GO:0010468 | regulation of gene expression | 34 | 4813 | 0.31 | TGFB1,HGF,APOE,CRP,FABP4,SORL1,LRP6,UCP1,KLKB1,ICAM1,PML,WNT3A,ACE,IGF1,MMP14,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,VEGFA,C19orf80 |
GO:0036293 | response to decreased oxygen levels | 9 | 354 | 0.87 | ICAM1,PML,ANGPTL4,MMP14,CTGF,EDN1,SOD3,ADIPOQ,VEGFA |
GO:1903827 | regulation of cellular protein localization | 11 | 568 | 0.75 | TGFB1,SORL1,PML,WNT3A,MMP14,TXN,INS,ITGB2,ADIPOQ,TNF,VEGFA |
GO:0045861 | negative regulation of proteolysis | 9 | 356 | 0.87 | HGF,SORL1,PML,NGF,AVP,INS,TNF,TNFAIP8,VEGFA |
GO:0050865 | regulation of cell activation | 11 | 571 | 0.75 | TGFB1,CCL2,APOE,WNT3A,IGF1,MMP14,CTGF,CD40LG,TLR4,THBD,ITGB2 |
GO:0045055 | regulated exocytosis | 12 | 697 | 0.7 | CEACAM6,TGFB1,HGF,MPO,CHI3L1,ALB,PTX3,LRG1,IGF1,ITGB2,GPI,VEGFA |
GO:0050766 | positive regulation of phagocytosis | 5 | 66 | 1.34 | CCL2,PTX3,APOA2,MBL2,TNF |
GO:0034392 | negative regulation of smooth muscle cell apoptotic process | 3 | 7 | 2.1 | LRP6,IGF1,EDN1 |
GO:0006955 | immune response | 18 | 1588 | 0.52 | CEACAM6,MPO,CCL2,CRP,CHI3L1,ICAM1,PML,PTX3,LRG1,CXCL8,IL6R,CD40LG,MBL2,TLR4,EDN1,ITGB2,TNF,GPI |
GO:0009987 | cellular process | 65 | 15024 | 0.1 | CEACAM6,TGFB1,EPOR,HGF,MPO,CCL2,APOE,CRP,CHI3L1,FABP4,MTNR1B,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,PLA2G7,WNT3A,ACE,ALB,PTX3,TNFRSF11B,NGB,ANGPTL4,LRG1,IGF1,CXCL8,MMP14,NAGPA,HBA1,AKR1B10,CYP2D6,MOK,CTGF,APOA2,IL6R,NGF,CD40LG,ANGPTL3,FNDC5,MBL2,DKK1,TLR4,TXN,THBD,EDN1,AVP,C1QTNF3,SOD3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,TNFAIP8,ENO2,FGF21,VEGFA,C19orf80 |
GO:0010605 | negative regulation of macromolecule metabolic process | 25 | 2875 | 0.4 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,PML,ACE,PTX3,IGF1,CTGF,APOA2,IL6R,NGF,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,INS,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:0009888 | tissue development | 19 | 1760 | 0.5 | TGFB1,EPOR,HGF,CHI3L1,LRP6,ICAM1,SEMA3A,PML,WNT3A,IGF1,MMP14,CTGF,MBL2,DKK1,EDN1,LAMA1,SPP1,ITGB2,VEGFA |
GO:0022409 | positive regulation of cell-cell adhesion | 8 | 272 | 0.93 | CEACAM6,CCL2,ICAM1,WNT3A,IGF1,CD40LG,ITGB2,TNF |
GO:0002688 | regulation of leukocyte chemotaxis | 6 | 124 | 1.15 | CCL2,PLA2G7,CXCL8,IL6R,EDN1,VEGFA |
GO:0007435 | salivary gland morphogenesis | 4 | 30 | 1.59 | TGFB1,SEMA3A,LAMA1,TNF |
GO:0050715 | positive regulation of cytokine secretion | 4 | 30 | 1.59 | SORL1,C1QTNF3,INS,TNF |
GO:0050873 | brown fat cell differentiation | 4 | 30 | 1.59 | FABP4,UCP1,LRG1,ADIPOQ |
GO:0061045 | negative regulation of wound healing | 5 | 70 | 1.32 | APOE,KLKB1,THBD,EDN1,TNF |
GO:0030278 | regulation of ossification | 7 | 197 | 1.02 | TGFB1,HGF,LRP6,IGF1,IL6R,DKK1,TNF |
GO:0000302 | response to reactive oxygen species | 7 | 198 | 1.01 | MPO,APOE,UCP1,HBA1,TXN,EDN1,SOD3 |
GO:0045862 | positive regulation of proteolysis | 9 | 377 | 0.84 | APOE,KLKB1,PML,WNT3A,MMP14,CTGF,NGF,TNF,C19orf80 |
GO:1901889 | negative regulation of cell junction assembly | 4 | 32 | 1.56 | ACE,MMP14,DKK1,TNF |
GO:1902003 | regulation of amyloid-beta formation | 4 | 32 | 1.56 | APOE,SORL1,IGF1,TNF |
GO:0009653 | anatomical structure morphogenesis | 21 | 2165 | 0.45 | TGFB1,HGF,CCL2,APOE,LRP6,SEMA3A,PML,WNT3A,ANGPTL4,CXCL8,MMP14,CTGF,NGF,ANGPTL3,MBL2,DKK1,EDN1,LAMA1,ITGB2,TNF,VEGFA |
GO:0001101 | response to acid chemical | 6 | 131 | 1.13 | ICAM1,CTGF,EDN1,TNF,FGF21,VEGFA |
GO:0048754 | branching morphogenesis of an epithelial tube | 6 | 131 | 1.13 | LRP6,PML,MMP14,EDN1,LAMA1,VEGFA |
GO:0008283 | cell population proliferation | 10 | 493 | 0.77 | HGF,LRP6,WNT3A,ACE,IGF1,MMP14,CTGF,CD40LG,TLR4,TNF |
GO:0071363 | cellular response to growth factor stimulus | 10 | 494 | 0.77 | TGFB1,HGF,CCL2,PML,CXCL8,CTGF,NGF,EDN1,FGF21,VEGFA |
GO:0045598 | regulation of fat cell differentiation | 6 | 133 | 1.12 | TGFB1,WNT3A,FNDC5,INS,ADIPOQ,TNF |
GO:0008228 | opsonization | 3 | 9 | 1.99 | CRP,PTX3,MBL2 |
GO:0016042 | lipid catabolic process | 8 | 294 | 0.9 | APOE,FABP4,PLA2G7,AKR1B10,APOA2,ANGPTL3,SPP1,ADIPOQ |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 4 | 34 | 1.54 | TGFB1,CCL2,TLR4,TNF |
GO:0048646 | anatomical structure formation involved in morphogenesis | 13 | 883 | 0.63 | TGFB1,CCL2,LRP6,WNT3A,ANGPTL4,CXCL8,MMP14,CTGF,ANGPTL3,DKK1,EDN1,ITGB2,VEGFA |
GO:0006928 | movement of cell or subcellular component | 17 | 1501 | 0.52 | CEACAM6,TGFB1,HGF,CCL2,ICAM1,SEMA3A,PML,WNT3A,CXCL8,MMP14,CTGF,IL6R,THBD,LAMA1,ITGB2,TNF,VEGFA |
GO:0071495 | cellular response to endogenous stimulus | 15 | 1181 | 0.57 | TGFB1,CCL2,UCP1,ICAM1,PML,IGF1,CXCL8,CTGF,NGF,TLR4,EDN1,INS,ADIPOQ,TNF,FGF21 |
GO:1901215 | negative regulation of neuron death | 7 | 211 | 0.99 | CCL2,APOE,MTNR1B,SORL1,WNT3A,NGF,FGF21 |
GO:0050878 | regulation of body fluid levels | 10 | 509 | 0.76 | APOE,KLKB1,WNT3A,CD40LG,TLR4,THBD,EDN1,AVP,GPI,VEGFA |
GO:0050792 | regulation of viral process | 7 | 215 | 0.98 | APOE,CRP,PML,PTX3,CXCL8,MBL2,TNF |
GO:0061041 | regulation of wound healing | 6 | 140 | 1.1 | APOE,KLKB1,TLR4,THBD,EDN1,TNF |
GO:0090322 | regulation of superoxide metabolic process | 4 | 36 | 1.51 | TGFB1,CRP,ITGB2,TNF |
GO:0009891 | positive regulation of biosynthetic process | 20 | 2040 | 0.46 | TGFB1,HGF,CCL2,APOE,LRP6,ICAM1,PML,WNT3A,PTX3,IGF1,CTGF,TLR4,EDN1,AVP,SPP1,INS,ITGB2,TNF,FGF21,VEGFA |
GO:0030193 | regulation of blood coagulation | 5 | 80 | 1.26 | APOE,KLKB1,TLR4,THBD,EDN1 |
GO:1900407 | regulation of cellular response to oxidative stress | 5 | 81 | 1.26 | HGF,TLR4,TXN,INS,TNF |
GO:0060562 | epithelial tube morphogenesis | 8 | 307 | 0.88 | TGFB1,LRP6,PML,WNT3A,MMP14,EDN1,LAMA1,VEGFA |
GO:0001933 | negative regulation of protein phosphorylation | 9 | 411 | 0.81 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,DKK1,TLR4,ADIPOQ |
GO:0014070 | response to organic cyclic compound | 13 | 911 | 0.62 | TGFB1,CCL2,LRP6,ICAM1,MMP14,CTGF,APOA2,THBD,EDN1,AVP,SPP1,ADIPOQ,TNF |
GO:0031324 | negative regulation of cellular metabolic process | 23 | 2630 | 0.41 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,PML,PTX3,IGF1,CYP2D6,NGF,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:0048732 | gland development | 9 | 410 | 0.81 | TGFB1,HGF,LRP6,SEMA3A,PML,WNT3A,LAMA1,TNF,VEGFA |
GO:0120161 | regulation of cold-induced thermogenesis | 6 | 144 | 1.09 | FABP4,UCP1,TLR4,ADIPOQ,FGF21,VEGFA |
GO:0043491 | protein kinase B signaling | 4 | 38 | 1.49 | TGFB1,CCL2,IGF1,TNF |
GO:0046326 | positive regulation of glucose import | 4 | 38 | 1.49 | IGF1,INS,ADIPOQ,FGF21 |
GO:0097756 | negative regulation of blood vessel diameter | 4 | 38 | 1.49 | CRP,EDN1,AVP,INS |
GO:0032642 | regulation of chemokine production | 5 | 84 | 1.24 | IL6R,TLR4,C1QTNF3,ADIPOQ,TNF |
GO:0050921 | positive regulation of chemotaxis | 6 | 147 | 1.08 | TGFB1,PLA2G7,CXCL8,IL6R,EDN1,VEGFA |
GO:0051171 | regulation of nitrogen compound metabolic process | 37 | 5836 | 0.27 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,SORL1,LRP6,UCP1,DESI1,KLKB1,ICAM1,SEMA3A,PML,WNT3A,ACE,PTX3,IGF1,MMP14,CTGF,IL6R,NGF,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,SPP1,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,FGF21,VEGFA,C19orf80 |
GO:0001525 | angiogenesis | 8 | 315 | 0.87 | CCL2,ANGPTL4,CXCL8,MMP14,CTGF,ANGPTL3,EDN1,VEGFA |
GO:0044419 | interspecies interaction between organisms | 19 | 1899 | 0.47 | TGFB1,MPO,CCL2,APOE,CRP,FABP4,ICAM1,PML,PTX3,LRG1,CXCL8,APOA2,IL6R,MBL2,TLR4,THBD,EDN1,ADIPOQ,TNF |
GO:0010632 | regulation of epithelial cell migration | 7 | 227 | 0.95 | TGFB1,APOE,SEMA3A,EDN1,TNF,GPI,VEGFA |
GO:0045785 | positive regulation of cell adhesion | 9 | 423 | 0.79 | CEACAM6,CCL2,ICAM1,WNT3A,IGF1,CD40LG,ITGB2,TNF,VEGFA |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 5 | 87 | 1.22 | EPOR,HGF,IGF1,INS,TNF |
GO:0002700 | regulation of production of molecular mediator of immune response | 6 | 152 | 1.06 | TGFB1,APOA2,CD40LG,TLR4,TNF,GPI |
GO:0110110 | positive regulation of animal organ morphogenesis | 5 | 89 | 1.22 | PML,WNT3A,DKK1,EDN1,VEGFA |
GO:0045123 | cellular extravasation | 4 | 42 | 1.44 | CCL2,ICAM1,ITGB2,TNF |
GO:0048545 | response to steroid hormone | 8 | 328 | 0.85 | TGFB1,ICAM1,CTGF,APOA2,EDN1,SPP1,ADIPOQ,TNF |
GO:0002009 | morphogenesis of an epithelium | 9 | 435 | 0.78 | TGFB1,LRP6,SEMA3A,PML,WNT3A,MMP14,EDN1,LAMA1,VEGFA |
GO:0051651 | maintenance of location in cell | 5 | 91 | 1.21 | APOE,SORL1,PML,ALB,TXN |
GO:0002696 | positive regulation of leukocyte activation | 8 | 332 | 0.85 | TGFB1,CCL2,WNT3A,IGF1,MMP14,CD40LG,TLR4,ITGB2 |
GO:0048638 | regulation of developmental growth | 8 | 333 | 0.85 | APOE,SEMA3A,WNT3A,IGF1,NGF,EDN1,SPP1,VEGFA |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 6 | 158 | 1.04 | ICAM1,CD40LG,TLR4,INS,ITGB2,TNF |
GO:0006953 | acute-phase response | 4 | 44 | 1.42 | CRP,IL6R,MBL2,INS |
GO:0032715 | negative regulation of interleukin-6 production | 4 | 44 | 1.42 | HGF,TLR4,C1QTNF3,TNF |
GO:0051051 | negative regulation of transport | 9 | 443 | 0.77 | APOE,MTNR1B,ICAM1,APOA2,TXN,EDN1,INS,ADIPOQ,TNF |
GO:0045936 | negative regulation of phosphate metabolic process | 10 | 561 | 0.72 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,DKK1,TLR4,ADIPOQ,TNF |
GO:0009887 | animal organ morphogenesis | 13 | 967 | 0.59 | TGFB1,CCL2,LRP6,SEMA3A,PML,WNT3A,MMP14,CTGF,MBL2,EDN1,LAMA1,TNF,VEGFA |
GO:0044087 | regulation of cellular component biogenesis | 13 | 971 | 0.59 | TGFB1,APOE,SORL1,ICAM1,WNT3A,ACE,MMP14,CTGF,DKK1,TLR4,EDN1,TNF,VEGFA |
GO:0045833 | negative regulation of lipid metabolic process | 5 | 95 | 1.19 | APOE,SORL1,APOA2,INS,TNF |
GO:0050804 | modulation of chemical synaptic transmission | 9 | 446 | 0.77 | CCL2,APOE,WNT3A,NGF,DKK1,EDN1,INS,ADIPOQ,TNF |
GO:0001666 | response to hypoxia | 8 | 342 | 0.83 | ICAM1,PML,ANGPTL4,MMP14,EDN1,SOD3,ADIPOQ,VEGFA |
GO:0002690 | positive regulation of leukocyte chemotaxis | 5 | 98 | 1.17 | PLA2G7,CXCL8,IL6R,EDN1,VEGFA |
GO:0010594 | regulation of endothelial cell migration | 6 | 164 | 1.03 | TGFB1,APOE,EDN1,TNF,GPI,VEGFA |
GO:0010951 | negative regulation of endopeptidase activity | 7 | 248 | 0.92 | HGF,SORL1,NGF,AVP,TNF,TNFAIP8,VEGFA |
GO:0031960 | response to corticosteroid | 6 | 164 | 1.03 | ICAM1,CTGF,APOA2,EDN1,ADIPOQ,TNF |
GO:0043255 | regulation of carbohydrate biosynthetic process | 5 | 97 | 1.18 | TGFB1,IGF1,C1QTNF3,INS,ADIPOQ |
GO:0120162 | positive regulation of cold-induced thermogenesis | 5 | 97 | 1.18 | FABP4,UCP1,ADIPOQ,FGF21,VEGFA |
GO:1901216 | positive regulation of neuron death | 5 | 98 | 1.17 | APOE,DKK1,TLR4,ITGB2,TNF |
GO:1902430 | negative regulation of amyloid-beta formation | 3 | 14 | 1.8 | APOE,SORL1,IGF1 |
GO:1903829 | positive regulation of cellular protein localization | 8 | 342 | 0.83 | TGFB1,SORL1,PML,WNT3A,INS,ITGB2,TNF,VEGFA |
GO:1905953 | negative regulation of lipid localization | 4 | 46 | 1.4 | APOE,CRP,APOA2,TNF |
GO:0030195 | negative regulation of blood coagulation | 4 | 47 | 1.4 | APOE,KLKB1,THBD,EDN1 |
GO:0045599 | negative regulation of fat cell differentiation | 4 | 48 | 1.39 | TGFB1,WNT3A,ADIPOQ,TNF |
GO:0097191 | extrinsic apoptotic signaling pathway | 5 | 100 | 1.16 | TGFB1,PML,IL6R,NGF,TNF |
GO:0002274 | myeloid leukocyte activation | 10 | 585 | 0.7 | CEACAM6,MPO,CHI3L1,PTX3,LRG1,CXCL8,TLR4,ITGB2,TNF,GPI |
GO:0031952 | regulation of protein autophosphorylation | 4 | 49 | 1.38 | ACE,INS,ADIPOQ,VEGFA |
GO:0051216 | cartilage development | 6 | 171 | 1.01 | TGFB1,CHI3L1,LRP6,CTGF,MBL2,EDN1 |
GO:0051897 | positive regulation of protein kinase B signaling | 6 | 170 | 1.01 | TGFB1,HGF,CHI3L1,TXN,INS,TNF |
GO:0043117 | positive regulation of vascular permeability | 3 | 16 | 1.74 | TGFB1,APOE,VEGFA |
GO:0062014 | negative regulation of small molecule metabolic process | 5 | 104 | 1.15 | TGFB1,APOE,C1QTNF3,INS,ADIPOQ |
GO:1903076 | regulation of protein localization to plasma membrane | 5 | 104 | 1.15 | TGFB1,WNT3A,MMP14,INS,TNF |
GO:0043112 | receptor metabolic process | 5 | 105 | 1.14 | TGFB1,SORL1,CXCL8,ITGB2,TNF |
GO:0048525 | negative regulation of viral process | 5 | 105 | 1.14 | CRP,PML,PTX3,MBL2,TNF |
GO:1901652 | response to peptide | 9 | 476 | 0.74 | LRP6,ICAM1,IGF1,CTGF,TLR4,EDN1,INS,ADIPOQ,FGF21 |
GO:0031400 | negative regulation of protein modification process | 10 | 602 | 0.69 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,DKK1,TLR4,ADIPOQ,TNF |
GO:0044281 | small molecule metabolic process | 17 | 1684 | 0.47 | TGFB1,HGF,MPO,APOE,PLA2G7,IGF1,AKR1B10,CYP2D6,APOA2,ANGPTL3,TXN,EDN1,INS,ADIPOQ,TNF,GPI,ENO2 |
GO:0050769 | positive regulation of neurogenesis | 9 | 479 | 0.74 | TGFB1,HGF,APOE,SEMA3A,WNT3A,NGF,DKK1,TNF,VEGFA |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 21 | 2429 | 0.4 | TGFB1,HGF,APOE,FABP4,SORL1,LRP6,PML,PTX3,IGF1,NGF,DKK1,TLR4,TXN,EDN1,AVP,INS,ITGB2,ADIPOQ,TNF,TNFAIP8,VEGFA |
GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 4 | 52 | 1.35 | IGF1,EDN1,ADIPOQ,TNF |
GO:0000165 | MAPK cascade | 8 | 370 | 0.8 | TGFB1,HGF,CCL2,IGF1,MOK,CD40LG,AVP,TNF |
GO:0001541 | ovarian follicle development | 4 | 53 | 1.34 | ICAM1,PTX3,MMP14,VEGFA |
GO:0046883 | regulation of hormone secretion | 7 | 268 | 0.88 | MTNR1B,EDN1,C1QTNF3,SPP1,INS,ADIPOQ,TNF |
GO:0060192 | negative regulation of lipase activity | 3 | 17 | 1.71 | ANGPTL4,APOA2,ANGPTL3 |
GO:1901222 | regulation of NIK/NF-kappaB signaling | 5 | 110 | 1.12 | CHI3L1,TLR4,EDN1,C1QTNF3,TNF |
GO:0007568 | aging | 7 | 274 | 0.87 | MPO,ICAM1,PML,CTGF,DKK1,EDN1,ITGB2 |
GO:0032757 | positive regulation of interleukin-8 production | 4 | 55 | 1.33 | APOA2,TLR4,ADIPOQ,TNF |
GO:0034375 | high-density lipoprotein particle remodeling | 3 | 18 | 1.69 | APOE,ALB,APOA2 |
GO:0045721 | negative regulation of gluconeogenesis | 3 | 18 | 1.69 | C1QTNF3,INS,ADIPOQ |
GO:0051023 | regulation of immunoglobulin secretion | 3 | 18 | 1.69 | CD40LG,TNF,GPI |
GO:0071222 | cellular response to lipopolysaccharide | 6 | 185 | 0.98 | TGFB1,CCL2,ICAM1,CXCL8,TLR4,TNF |
GO:0072593 | reactive oxygen species metabolic process | 5 | 112 | 1.12 | MPO,HBA1,CTGF,EDN1,SOD3 |
GO:0002446 | neutrophil mediated immunity | 9 | 495 | 0.73 | CEACAM6,MPO,CHI3L1,ACE,PTX3,LRG1,IL6R,ITGB2,GPI |
GO:0007159 | leukocyte cell-cell adhesion | 4 | 56 | 1.32 | ICAM1,CD40LG,ITGB2,TNF |
GO:0019725 | cellular homeostasis | 12 | 895 | 0.59 | MPO,CCL2,APOE,MTNR1B,LRP6,ICAM1,PML,TXN,EDN1,AVP,C1QTNF3,FGF21 |
GO:0050770 | regulation of axonogenesis | 6 | 187 | 0.97 | APOE,SEMA3A,WNT3A,NGF,SPP1,VEGFA |
GO:0050776 | regulation of immune response | 12 | 896 | 0.59 | TGFB1,APOE,CRP,ICAM1,APOA2,CD40LG,MBL2,TLR4,INS,ITGB2,MUC16,TNF |
GO:0051130 | positive regulation of cellular component organization | 14 | 1209 | 0.53 | TGFB1,HGF,APOE,ICAM1,PML,WNT3A,IGF1,CTGF,NGF,TLR4,EDN1,INS,TNF,VEGFA |
GO:0001501 | skeletal system development | 9 | 499 | 0.72 | TGFB1,CHI3L1,LRP6,TNFRSF11B,IGF1,MMP14,CTGF,MBL2,EDN1 |
GO:0002366 | leukocyte activation involved in immune response | 10 | 626 | 0.67 | CEACAM6,MPO,CHI3L1,ICAM1,PTX3,LRG1,CD40LG,TLR4,ITGB2,GPI |
GO:0022604 | regulation of cell morphogenesis | 9 | 498 | 0.72 | CCL2,APOE,ICAM1,SEMA3A,WNT3A,NGF,SPP1,ITGB2,VEGFA |
GO:0032535 | regulation of cellular component size | 8 | 383 | 0.79 | APOE,ICAM1,SEMA3A,WNT3A,NGF,EDN1,SPP1,VEGFA |
GO:0043200 | response to amino acid | 5 | 114 | 1.11 | ICAM1,CTGF,EDN1,TNF,FGF21 |
GO:0051353 | positive regulation of oxidoreductase activity | 4 | 57 | 1.31 | APOE,EDN1,INS,TNF |
GO:0006006 | glucose metabolic process | 5 | 116 | 1.1 | INS,ADIPOQ,TNF,GPI,ENO2 |
GO:0032368 | regulation of lipid transport | 5 | 116 | 1.1 | APOE,APOA2,EDN1,SPP1,ADIPOQ |
GO:0051251 | positive regulation of lymphocyte activation | 7 | 286 | 0.85 | TGFB1,CCL2,WNT3A,IGF1,MMP14,CD40LG,TLR4 |
GO:0051781 | positive regulation of cell division | 5 | 117 | 1.1 | TGFB1,IGF1,EDN1,INS,VEGFA |
GO:0019229 | regulation of vasoconstriction | 4 | 59 | 1.3 | ICAM1,ACE,EDN1,AVP |
GO:0032930 | positive regulation of superoxide anion generation | 3 | 20 | 1.64 | TGFB1,CRP,ITGB2 |
GO:0044242 | cellular lipid catabolic process | 6 | 196 | 0.95 | FABP4,PLA2G7,AKR1B10,APOA2,ANGPTL3,ADIPOQ |
GO:0050768 | negative regulation of neurogenesis | 7 | 287 | 0.85 | APOE,SORL1,SEMA3A,WNT3A,DKK1,SPP1,TNF |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 3 | 20 | 1.64 | CCL2,TLR4,EDN1 |
GO:1901698 | response to nitrogen compound | 13 | 1070 | 0.55 | LRP6,ICAM1,IGF1,CTGF,TLR4,TXN,THBD,EDN1,INS,ITGB2,ADIPOQ,TNF,FGF21 |
GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell | 3 | 20 | 1.64 | ICAM1,ITGB2,TNF |
GO:0045912 | negative regulation of carbohydrate metabolic process | 4 | 60 | 1.29 | TGFB1,C1QTNF3,INS,ADIPOQ |
GO:0060541 | respiratory system development | 6 | 197 | 0.95 | CHI3L1,LRP6,MMP14,CTGF,LAMA1,VEGFA |
GO:1905475 | regulation of protein localization to membrane | 6 | 198 | 0.95 | TGFB1,WNT3A,MMP14,INS,ITGB2,TNF |
GO:0032722 | positive regulation of chemokine production | 4 | 61 | 1.28 | IL6R,TLR4,ADIPOQ,TNF |
GO:0048670 | regulation of collateral sprouting | 3 | 21 | 1.62 | WNT3A,NGF,SPP1 |
GO:1901888 | regulation of cell junction assembly | 6 | 199 | 0.94 | WNT3A,ACE,MMP14,DKK1,TNF,VEGFA |
GO:0014910 | regulation of smooth muscle cell migration | 4 | 62 | 1.28 | SORL1,ACE,IGF1,ADIPOQ |
GO:0097529 | myeloid leukocyte migration | 5 | 123 | 1.07 | CCL2,CXCL8,IL6R,ITGB2,VEGFA |
GO:0060326 | cell chemotaxis | 6 | 204 | 0.93 | HGF,CCL2,CXCL8,IL6R,ITGB2,VEGFA |
GO:0051000 | positive regulation of nitric-oxide synthase activity | 3 | 22 | 1.6 | APOE,INS,TNF |
GO:0051004 | regulation of lipoprotein lipase activity | 3 | 22 | 1.6 | ANGPTL4,ANGPTL3,C19orf80 |
GO:0051641 | cellular localization | 23 | 2967 | 0.35 | CEACAM6,TGFB1,HGF,MPO,APOE,CHI3L1,SORL1,LRP6,DESI1,PML,WNT3A,ALB,PTX3,LRG1,IGF1,NAGPA,TXN,INS,ITGB2,ADIPOQ,TNF,GPI,VEGFA |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 3 | 22 | 1.6 | HGF,IGF1,AVP |
GO:0002576 | platelet degranulation | 5 | 129 | 1.05 | TGFB1,HGF,ALB,IGF1,VEGFA |
GO:0010869 | regulation of receptor biosynthetic process | 3 | 23 | 1.58 | EDN1,ADIPOQ,FGF21 |
GO:0051649 | establishment of localization in cell | 20 | 2375 | 0.39 | CEACAM6,TGFB1,HGF,MPO,APOE,CHI3L1,SORL1,LRP6,DESI1,PML,WNT3A,ALB,PTX3,LRG1,IGF1,NAGPA,INS,ITGB2,GPI,VEGFA |
GO:0045995 | regulation of embryonic development | 5 | 130 | 1.05 | WNT3A,IGF1,DKK1,LAMA1,ADIPOQ |
GO:0040013 | negative regulation of locomotion | 7 | 310 | 0.82 | TGFB1,CCL2,APOE,SEMA3A,WNT3A,ADIPOQ,TNF |
GO:0043393 | regulation of protein binding | 6 | 212 | 0.92 | APOE,SORL1,WNT3A,ACE,DKK1,ADIPOQ |
GO:0060485 | mesenchyme development | 6 | 212 | 0.92 | TGFB1,HGF,LRP6,SEMA3A,WNT3A,EDN1 |
GO:1903201 | regulation of oxidative stress-induced cell death | 4 | 67 | 1.24 | HGF,TLR4,TXN,INS |
GO:0010954 | positive regulation of protein processing | 3 | 24 | 1.56 | KLKB1,MMP14,C19orf80 |
GO:0051271 | negative regulation of cellular component movement | 7 | 311 | 0.82 | TGFB1,CCL2,APOE,SEMA3A,WNT3A,ADIPOQ,TNF |
GO:0006935 | chemotaxis | 9 | 545 | 0.68 | HGF,CCL2,SEMA3A,WNT3A,CXCL8,IL6R,LAMA1,ITGB2,VEGFA |
GO:0008152 | metabolic process | 44 | 8298 | 0.19 | TGFB1,HGF,MPO,CCL2,APOE,CHI3L1,FABP4,SORL1,UCP1,DESI1,KLKB1,PML,PLA2G7,ACE,ALB,ANGPTL4,IGF1,CXCL8,MMP14,NAGPA,HBA1,AKR1B10,CYP2D6,MOK,CTGF,APOA2,NGF,CD40LG,ANGPTL3,TLR4,TXN,EDN1,AVP,SOD3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,ENO2,C19orf80 |
GO:0001936 | regulation of endothelial cell proliferation | 5 | 134 | 1.04 | CCL2,APOE,LRG1,TNF,VEGFA |
GO:0010629 | negative regulation of gene expression | 18 | 2014 | 0.42 | TGFB1,HGF,APOE,FABP4,PML,ACE,IGF1,CTGF,APOA2,IL6R,DKK1,TLR4,TXN,EDN1,C1QTNF3,ADIPOQ,TNF,VEGFA |
GO:0010633 | negative regulation of epithelial cell migration | 4 | 69 | 1.23 | TGFB1,APOE,SEMA3A,TNF |
GO:0014823 | response to activity | 4 | 69 | 1.23 | FNDC5,EDN1,ADIPOQ,FGF21 |
GO:1902996 | regulation of neurofibrillary tangle assembly | 2 | 3 | 2.29 | APOE,SORL1 |
GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation | 2 | 3 | 2.29 | ACE,TXN |
GO:0002637 | regulation of immunoglobulin production | 4 | 70 | 1.22 | TGFB1,CD40LG,TNF,GPI |
GO:0002719 | negative regulation of cytokine production involved in immune response | 3 | 25 | 1.54 | TGFB1,APOA2,TNF |
GO:0032370 | positive regulation of lipid transport | 4 | 70 | 1.22 | APOE,EDN1,SPP1,ADIPOQ |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 3 | 25 | 1.54 | CEACAM6,ADIPOQ,TNF |
GO:0050767 | regulation of neurogenesis | 11 | 828 | 0.59 | TGFB1,HGF,APOE,SORL1,SEMA3A,WNT3A,NGF,DKK1,SPP1,TNF,VEGFA |
GO:0051224 | negative regulation of protein transport | 5 | 135 | 1.03 | APOE,MTNR1B,TXN,INS,ADIPOQ |
GO:0120035 | regulation of plasma membrane bounded cell projection organization | 10 | 687 | 0.63 | HGF,APOE,ICAM1,SEMA3A,WNT3A,NGF,DKK1,SPP1,INS,VEGFA |
GO:0022008 | neurogenesis | 16 | 1657 | 0.45 | TGFB1,HGF,CCL2,APOE,SORL1,LRP6,SEMA3A,WNT3A,MMP14,NGF,DKK1,TLR4,LAMA1,SPP1,TNF,VEGFA |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5 | 136 | 1.03 | PML,WNT3A,CTGF,NGF,TNF |
GO:0048660 | regulation of smooth muscle cell proliferation | 5 | 136 | 1.03 | IGF1,IL6R,EDN1,ADIPOQ,TNF |
GO:0010243 | response to organonitrogen compound | 12 | 987 | 0.55 | LRP6,ICAM1,IGF1,CTGF,TLR4,THBD,EDN1,INS,ITGB2,ADIPOQ,TNF,FGF21 |
GO:1903524 | positive regulation of blood circulation | 4 | 71 | 1.22 | ICAM1,CTGF,EDN1,AVP |
GO:0009749 | response to glucose | 5 | 138 | 1.02 | ICAM1,CTGF,APOA2,ADIPOQ,FGF21 |
GO:0009056 | catabolic process | 18 | 2042 | 0.41 | TGFB1,MPO,APOE,CHI3L1,FABP4,PML,PLA2G7,ACE,MMP14,HBA1,AKR1B10,CYP2D6,APOA2,ANGPTL3,SPP1,ADIPOQ,GPI,ENO2 |
GO:0050728 | negative regulation of inflammatory response | 5 | 139 | 1.02 | HGF,APOE,C1QTNF3,INS,ADIPOQ |
GO:0010876 | lipid localization | 7 | 326 | 0.8 | APOE,FABP4,LRP6,ACE,APOA2,ANGPTL3,TNF |
GO:0043507 | positive regulation of JUN kinase activity | 4 | 73 | 1.2 | CD40LG,DKK1,EDN1,TNF |
GO:0050996 | positive regulation of lipid catabolic process | 3 | 27 | 1.51 | APOA2,ANGPTL3,FGF21 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 3 | 27 | 1.51 | TGFB1,WNT3A,IGF1 |
GO:0030595 | leukocyte chemotaxis | 5 | 142 | 1.01 | CCL2,CXCL8,IL6R,ITGB2,VEGFA |
GO:0032675 | regulation of interleukin-6 production | 5 | 142 | 1.01 | HGF,IL6R,TLR4,C1QTNF3,TNF |
GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 6 | 228 | 0.89 | CCL2,ICAM1,IGF1,CD40LG,ITGB2,TNF |
GO:1901653 | cellular response to peptide | 7 | 331 | 0.79 | ICAM1,IGF1,TLR4,EDN1,INS,ADIPOQ,FGF21 |
GO:0009889 | regulation of biosynthetic process | 28 | 4210 | 0.29 | TGFB1,HGF,CCL2,APOE,FABP4,LRP6,UCP1,ICAM1,PML,WNT3A,PTX3,IGF1,CTGF,IL6R,CD40LG,DKK1,TLR4,TXN,EDN1,AVP,C1QTNF3,SPP1,INS,ITGB2,ADIPOQ,TNF,FGF21,VEGFA |
GO:0048568 | embryonic organ development | 8 | 448 | 0.72 | TGFB1,LRP6,WNT3A,CXCL8,MMP14,EDN1,TNF,VEGFA |
GO:0050729 | positive regulation of inflammatory response | 5 | 144 | 1.01 | FABP4,KLKB1,PLA2G7,TLR4,TNF |
GO:0062013 | positive regulation of small molecule metabolic process | 5 | 144 | 1.01 | IGF1,AVP,INS,ADIPOQ,TNF |
GO:0002021 | response to dietary excess | 3 | 28 | 1.5 | APOE,SORL1,UCP1 |
GO:0031954 | positive regulation of protein autophosphorylation | 3 | 28 | 1.5 | ACE,INS,VEGFA |
GO:0055094 | response to lipoprotein particle | 3 | 28 | 1.5 | TLR4,ITGB2,FGF21 |
GO:0062012 | regulation of small molecule metabolic process | 8 | 449 | 0.72 | TGFB1,APOE,IGF1,AVP,C1QTNF3,INS,ADIPOQ,TNF |
GO:2001234 | negative regulation of apoptotic signaling pathway | 6 | 232 | 0.88 | HGF,ICAM1,IGF1,AVP,INS,TNF |
GO:0043254 | regulation of protein-containing complex assembly | 8 | 451 | 0.71 | TGFB1,APOE,SORL1,ICAM1,DKK1,TLR4,TNF,VEGFA |
GO:0034103 | regulation of tissue remodeling | 4 | 77 | 1.18 | TGFB1,PML,TNFRSF11B,SPP1 |
GO:0051384 | response to glucocorticoid | 5 | 147 | 1 | ICAM1,APOA2,EDN1,ADIPOQ,TNF |
GO:0051450 | myoblast proliferation | 2 | 4 | 2.16 | HGF,IGF1 |
GO:0090245 | axis elongation involved in somitogenesis | 2 | 4 | 2.16 | LRP6,WNT3A |
GO:1902952 | positive regulation of dendritic spine maintenance | 2 | 4 | 2.16 | APOE,INS |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5 | 148 | 0.99 | CRP,ICAM1,CD40LG,MBL2,TLR4 |
GO:0044788 | modulation by host of viral process | 3 | 29 | 1.48 | APOE,CRP,PTX3 |
GO:0045940 | positive regulation of steroid metabolic process | 3 | 29 | 1.48 | APOE,APOA2,TNF |
GO:2000352 | negative regulation of endothelial cell apoptotic process | 3 | 29 | 1.48 | ICAM1,ANGPTL4,FGF21 |
GO:0035556 | intracellular signal transduction | 16 | 1712 | 0.44 | TGFB1,HGF,CCL2,APOE,CHI3L1,PML,IGF1,CXCL8,MOK,CTGF,NGF,CD40LG,TLR4,EDN1,AVP,TNF |
GO:0010977 | negative regulation of neuron projection development | 5 | 151 | 0.99 | APOE,SEMA3A,WNT3A,DKK1,SPP1 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 3 | 30 | 1.47 | TLR4,ITGB2,FGF21 |
GO:0071542 | dopaminergic neuron differentiation | 3 | 30 | 1.47 | LRP6,WNT3A,VEGFA |
GO:0048762 | mesenchymal cell differentiation | 5 | 152 | 0.98 | TGFB1,HGF,LRP6,SEMA3A,EDN1 |
GO:0009896 | positive regulation of catabolic process | 8 | 465 | 0.7 | APOE,SORL1,IGF1,APOA2,ANGPTL3,INS,TNF,FGF21 |
GO:0071621 | granulocyte chemotaxis | 4 | 81 | 1.16 | CCL2,CXCL8,ITGB2,VEGFA |
GO:0005975 | carbohydrate metabolic process | 8 | 467 | 0.7 | CHI3L1,NAGPA,ANGPTL3,INS,ADIPOQ,TNF,GPI,ENO2 |
GO:1903531 | negative regulation of secretion by cell | 5 | 153 | 0.98 | APOE,MTNR1B,EDN1,INS,ADIPOQ |
GO:0048841 | regulation of axon extension involved in axon guidance | 3 | 31 | 1.45 | SEMA3A,WNT3A,VEGFA |
GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 4 | 82 | 1.15 | CHI3L1,TLR4,EDN1,TNF |
GO:0000187 | activation of MAPK activity | 5 | 157 | 0.97 | HGF,IGF1,CD40LG,TLR4,TNF |
GO:0032148 | activation of protein kinase B activity | 3 | 32 | 1.44 | IGF1,TXN,INS |
GO:0003008 | system process | 17 | 1942 | 0.41 | TGFB1,CCL2,APOE,CRP,MTNR1B,ICAM1,ACE,IGF1,NGF,DKK1,TLR4,EDN1,AVP,INS,ADIPOQ,TNF,VEGFA |
GO:0009996 | negative regulation of cell fate specification | 2 | 5 | 2.07 | WNT3A,DKK1 |
GO:0090244 | Wnt signaling pathway involved in somitogenesis | 2 | 5 | 2.07 | LRP6,DKK1 |
GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation | 2 | 5 | 2.07 | ACE,VEGFA |
GO:0007369 | gastrulation | 5 | 159 | 0.96 | LRP6,WNT3A,MMP14,DKK1,ITGB2 |
GO:0032651 | regulation of interleukin-1 beta production | 4 | 85 | 1.14 | PML,IGF1,TLR4,TNF |
GO:0042632 | cholesterol homeostasis | 4 | 85 | 1.14 | APOE,FABP4,APOA2,ANGPTL3 |
GO:0046889 | positive regulation of lipid biosynthetic process | 4 | 85 | 1.14 | APOE,AVP,INS,TNF |
GO:0050871 | positive regulation of B cell activation | 4 | 85 | 1.14 | TGFB1,WNT3A,MMP14,TLR4 |
GO:0098542 | defense response to other organism | 11 | 900 | 0.55 | MPO,CCL2,CRP,ICAM1,PML,PTX3,IL6R,MBL2,TLR4,EDN1,TNF |
GO:0071346 | cellular response to interferon-gamma | 5 | 161 | 0.96 | CCL2,ICAM1,PML,TLR4,EDN1 |
GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 5 | 161 | 0.96 | HGF,ICAM1,PML,IGF1,TNF |
GO:0010543 | regulation of platelet activation | 3 | 34 | 1.41 | APOE,TLR4,THBD |
GO:0045778 | positive regulation of ossification | 4 | 88 | 1.12 | TGFB1,HGF,IGF1,IL6R |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 4 | 88 | 1.12 | IGF1,IL6R,EDN1,TNF |
GO:0002718 | regulation of cytokine production involved in immune response | 4 | 89 | 1.12 | TGFB1,APOA2,TLR4,TNF |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 3 | 35 | 1.4 | TGFB1,APOE,TNF |
GO:1901031 | regulation of response to reactive oxygen species | 3 | 35 | 1.4 | HGF,TXN,TNF |
GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 3 | 35 | 1.4 | IGF1,EDN1,TNF |
GO:0071704 | organic substance metabolic process | 41 | 7755 | 0.19 | TGFB1,HGF,MPO,CCL2,APOE,CHI3L1,FABP4,SORL1,DESI1,KLKB1,PML,PLA2G7,ACE,ALB,ANGPTL4,IGF1,CXCL8,MMP14,NAGPA,AKR1B10,CYP2D6,MOK,CTGF,APOA2,NGF,CD40LG,ANGPTL3,TLR4,TXN,EDN1,AVP,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,ENO2,C19orf80 |
GO:0030336 | negative regulation of cell migration | 6 | 262 | 0.83 | TGFB1,CCL2,APOE,SEMA3A,ADIPOQ,TNF |
GO:0042119 | neutrophil activation | 8 | 497 | 0.67 | CEACAM6,MPO,CHI3L1,PTX3,LRG1,CXCL8,ITGB2,GPI |
GO:0070542 | response to fatty acid | 4 | 91 | 1.11 | UCP1,CTGF,EDN1,ADIPOQ |
GO:0007182 | common-partner SMAD protein phosphorylation | 2 | 6 | 1.99 | TGFB1,PML |
GO:0042661 | regulation of mesodermal cell fate specification | 2 | 6 | 1.99 | WNT3A,DKK1 |
GO:0043615 | astrocyte cell migration | 2 | 6 | 1.99 | CCL2,MMP14 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 2 | 6 | 1.99 | ANGPTL4,ANGPTL3 |
GO:0051970 | negative regulation of transmission of nerve impulse | 2 | 6 | 1.99 | MTNR1B,AVP |
GO:0098801 | regulation of renal system process | 3 | 36 | 1.39 | EDN1,AVP,ADIPOQ |
GO:0001503 | ossification | 6 | 265 | 0.82 | TGFB1,WNT3A,IGF1,MMP14,CTGF,SPP1 |
GO:0030324 | lung development | 5 | 170 | 0.93 | CHI3L1,MMP14,CTGF,LAMA1,VEGFA |
GO:0043535 | regulation of blood vessel endothelial cell migration | 4 | 93 | 1.1 | TGFB1,APOE,TNF,VEGFA |
GO:0051702 | interaction with symbiont | 4 | 93 | 1.1 | APOE,CRP,PTX3,MBL2 |
GO:0006801 | superoxide metabolic process | 3 | 37 | 1.37 | MPO,EDN1,SOD3 |
GO:0019915 | lipid storage | 3 | 37 | 1.37 | APOE,ANGPTL3,TNF |
GO:0031328 | positive regulation of cellular biosynthetic process | 17 | 2005 | 0.39 | TGFB1,HGF,APOE,LRP6,ICAM1,PML,WNT3A,PTX3,IGF1,TLR4,EDN1,AVP,SPP1,INS,ITGB2,TNF,VEGFA |
GO:0032965 | regulation of collagen biosynthetic process | 3 | 37 | 1.37 | TGFB1,CTGF,IL6R |
GO:0070741 | response to interleukin-6 | 3 | 37 | 1.37 | CHI3L1,ICAM1,IL6R |
GO:0007229 | integrin-mediated signaling pathway | 4 | 94 | 1.09 | CTGF,CD40LG,ANGPTL3,ITGB2 |
GO:0048468 | cell development | 15 | 1629 | 0.43 | APOE,ICAM1,SEMA3A,WNT3A,PTX3,IGF1,NGF,MBL2,DKK1,TLR4,EDN1,LAMA1,TNF,VEGFA,C19orf80 |
GO:0051100 | negative regulation of binding | 5 | 173 | 0.93 | SORL1,ACE,CYP2D6,DKK1,ADIPOQ |
GO:0016310 | phosphorylation | 13 | 1275 | 0.47 | TGFB1,HGF,CCL2,PML,IGF1,MOK,CD40LG,TLR4,AVP,LAMA1,TNF,GPI,ENO2 |
GO:0071347 | cellular response to interleukin-1 | 5 | 174 | 0.92 | CCL2,CHI3L1,ICAM1,CXCL8,EDN1 |
GO:0010470 | regulation of gastrulation | 3 | 38 | 1.36 | WNT3A,DKK1,ADIPOQ |
GO:0010975 | regulation of neuron projection development | 8 | 510 | 0.66 | HGF,APOE,SEMA3A,WNT3A,NGF,DKK1,SPP1,VEGFA |
GO:0090207 | regulation of triglyceride metabolic process | 3 | 38 | 1.36 | APOE,SORL1,FGF21 |
GO:0048771 | tissue remodeling | 4 | 96 | 1.09 | TGFB1,LRP6,ACE,MMP14 |
GO:0006468 | protein phosphorylation | 11 | 952 | 0.53 | TGFB1,HGF,CCL2,PML,IGF1,MOK,CD40LG,TLR4,AVP,LAMA1,TNF |
GO:0048639 | positive regulation of developmental growth | 5 | 176 | 0.92 | WNT3A,IGF1,NGF,EDN1,VEGFA |
GO:0006959 | humoral immune response | 6 | 275 | 0.8 | CCL2,CRP,CXCL8,MBL2,TNF,GPI |
GO:0035282 | segmentation | 4 | 97 | 1.08 | LRP6,SEMA3A,WNT3A,DKK1 |
GO:0032733 | positive regulation of interleukin-10 production | 3 | 39 | 1.35 | HGF,CD40LG,TLR4 |
GO:0032885 | regulation of polysaccharide biosynthetic process | 3 | 39 | 1.35 | TGFB1,IGF1,INS |
GO:0033574 | response to testosterone | 3 | 39 | 1.35 | EDN1,AVP,SPP1 |
GO:1904646 | cellular response to amyloid-beta | 3 | 39 | 1.35 | ICAM1,IGF1,TLR4 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 8 | 518 | 0.65 | TGFB1,HGF,IGF1,CTGF,NGF,INS,FGF21,VEGFA |
GO:0042742 | defense response to bacterium | 6 | 277 | 0.8 | MPO,CRP,IL6R,MBL2,TLR4,TNF |
GO:0030516 | regulation of axon extension | 4 | 99 | 1.07 | APOE,SEMA3A,WNT3A,VEGFA |
GO:0034381 | plasma lipoprotein particle clearance | 3 | 40 | 1.34 | APOE,APOA2,ADIPOQ |
GO:0043065 | positive regulation of apoptotic process | 9 | 660 | 0.6 | CCL2,PML,WNT3A,CTGF,NGF,CD40LG,ADIPOQ,TNF,TNFAIP8 |
GO:0043434 | response to peptide hormone | 7 | 394 | 0.72 | LRP6,ICAM1,CTGF,EDN1,INS,ADIPOQ,FGF21 |
GO:0060191 | regulation of lipase activity | 4 | 99 | 1.07 | ANGPTL4,APOA2,ANGPTL3,C19orf80 |
GO:0090184 | positive regulation of kidney development | 3 | 40 | 1.34 | IL6R,ADIPOQ,VEGFA |
GO:0042493 | response to drug | 6 | 281 | 0.79 | TNFRSF11B,CYP2D6,APOA2,EDN1,ADIPOQ,FGF21 |
GO:0009395 | phospholipid catabolic process | 3 | 41 | 1.33 | PLA2G7,APOA2,ANGPTL3 |
GO:0097190 | apoptotic signaling pathway | 6 | 286 | 0.79 | TGFB1,PML,IL6R,NGF,TLR4,TNF |
GO:0009611 | response to wounding | 8 | 532 | 0.64 | TGFB1,KLKB1,WNT3A,CTGF,CD40LG,THBD,INS,VEGFA |
GO:0010595 | positive regulation of endothelial cell migration | 4 | 103 | 1.05 | TGFB1,EDN1,GPI,VEGFA |
GO:0030308 | negative regulation of cell growth | 5 | 187 | 0.89 | TGFB1,SEMA3A,PML,WNT3A,SPP1 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 2 | 8 | 1.86 | IGF1,EDN1 |
GO:0072577 | endothelial cell apoptotic process | 2 | 8 | 1.86 | TNF,FGF21 |
GO:0072683 | T cell extravasation | 2 | 8 | 1.86 | CCL2,ICAM1 |
GO:0042593 | glucose homeostasis | 5 | 188 | 0.89 | MTNR1B,ICAM1,INS,ADIPOQ,FGF21 |
GO:0071407 | cellular response to organic cyclic compound | 8 | 537 | 0.64 | TGFB1,CCL2,LRP6,ICAM1,EDN1,SPP1,ADIPOQ,TNF |
GO:0001937 | negative regulation of endothelial cell proliferation | 3 | 43 | 1.31 | CCL2,APOE,TNF |
GO:0010035 | response to inorganic substance | 8 | 538 | 0.64 | MPO,FABP4,ICAM1,TNFRSF11B,HBA1,TXN,EDN1,SOD3 |
GO:1903522 | regulation of blood circulation | 6 | 292 | 0.78 | ICAM1,SEMA3A,ACE,CTGF,EDN1,AVP |
GO:2001233 | regulation of apoptotic signaling pathway | 7 | 409 | 0.7 | HGF,ICAM1,PML,IGF1,AVP,INS,TNF |
GO:0032091 | negative regulation of protein binding | 4 | 106 | 1.04 | SORL1,ACE,DKK1,ADIPOQ |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 4 | 106 | 1.04 | HGF,ICAM1,IGF1,TNF |
GO:0044089 | positive regulation of cellular component biogenesis | 8 | 542 | 0.63 | TGFB1,APOE,ICAM1,CTGF,TLR4,EDN1,TNF,VEGFA |
GO:0051348 | negative regulation of transferase activity | 6 | 294 | 0.78 | APOE,FABP4,SORL1,LRP6,PML,ADIPOQ |
GO:0050679 | positive regulation of epithelial cell proliferation | 5 | 192 | 0.88 | WNT3A,LRG1,IGF1,TLR4,VEGFA |
GO:0001523 | retinoid metabolic process | 4 | 108 | 1.03 | APOE,AKR1B10,CYP2D6,APOA2 |
GO:0044344 | cellular response to fibroblast growth factor stimulus | 4 | 108 | 1.03 | CCL2,CXCL8,CTGF,FGF21 |
GO:0009790 | embryo development | 11 | 1002 | 0.51 | TGFB1,LRP6,SEMA3A,WNT3A,CXCL8,MMP14,DKK1,EDN1,ITGB2,TNF,VEGFA |
GO:0042445 | hormone metabolic process | 5 | 194 | 0.88 | ACE,AKR1B10,CYP2D6,NGF,SPP1 |
GO:0008285 | negative regulation of cell population proliferation | 9 | 696 | 0.58 | TGFB1,CCL2,APOE,CRP,PML,CXCL8,NGF,ADIPOQ,TNF |
GO:0010873 | positive regulation of cholesterol esterification | 2 | 9 | 1.81 | APOE,APOA2 |
GO:0034371 | chylomicron remodeling | 2 | 9 | 1.81 | APOE,APOA2 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 2 | 9 | 1.81 | ADIPOQ,FGF21 |
GO:0046890 | regulation of lipid biosynthetic process | 5 | 197 | 0.87 | APOE,AVP,INS,ADIPOQ,TNF |
GO:0048608 | reproductive structure development | 7 | 420 | 0.69 | EPOR,LRP6,ICAM1,PTX3,MMP14,SPP1,VEGFA |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 2 | 9 | 1.81 | HGF,TNF |
GO:0090209 | negative regulation of triglyceride metabolic process | 2 | 9 | 1.81 | APOE,SORL1 |
GO:0090381 | regulation of heart induction | 2 | 9 | 1.81 | WNT3A,DKK1 |
GO:1902966 | positive regulation of protein localization to early endosome | 2 | 9 | 1.81 | SORL1,VEGFA |
GO:0002673 | regulation of acute inflammatory response | 3 | 47 | 1.27 | KLKB1,INS,TNF |
GO:1901654 | response to ketone | 5 | 199 | 0.87 | TGFB1,ICAM1,EDN1,AVP,SPP1 |
GO:1903202 | negative regulation of oxidative stress-induced cell death | 3 | 47 | 1.27 | HGF,TXN,INS |
GO:0034762 | regulation of transmembrane transport | 8 | 560 | 0.62 | CCL2,MTNR1B,IGF1,EDN1,INS,ADIPOQ,TNF,FGF21 |
GO:0006629 | lipid metabolic process | 12 | 1190 | 0.47 | APOE,FABP4,PLA2G7,ANGPTL4,AKR1B10,CYP2D6,APOA2,ANGPTL3,EDN1,SPP1,ADIPOQ,C19orf80 |
GO:2000278 | regulation of DNA biosynthetic process | 4 | 114 | 1.01 | HGF,PML,ADIPOQ,VEGFA |
GO:0010749 | regulation of nitric oxide mediated signal transduction | 2 | 10 | 1.77 | INS,VEGFA |
GO:0034378 | chylomicron assembly | 2 | 10 | 1.77 | APOE,APOA2 |
GO:0034384 | high-density lipoprotein particle clearance | 2 | 10 | 1.77 | APOE,APOA2 |
GO:0035988 | chondrocyte proliferation | 2 | 10 | 1.77 | MMP14,CTGF |
GO:1901575 | organic substance catabolic process | 15 | 1750 | 0.4 | TGFB1,APOE,CHI3L1,FABP4,PML,PLA2G7,ACE,AKR1B10,CYP2D6,APOA2,ANGPTL3,SPP1,ADIPOQ,GPI,ENO2 |
GO:1904338 | regulation of dopaminergic neuron differentiation | 2 | 10 | 1.77 | WNT3A,DKK1 |
GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation | 2 | 10 | 1.77 | LRP6,WNT3A |
GO:0001704 | formation of primary germ layer | 4 | 116 | 1 | WNT3A,MMP14,DKK1,ITGB2 |
GO:0045667 | regulation of osteoblast differentiation | 4 | 117 | 1 | HGF,IGF1,IL6R,TNF |
GO:0007167 | enzyme linked receptor protein signaling pathway | 9 | 720 | 0.56 | TGFB1,HGF,PML,IGF1,CTGF,NGF,INS,FGF21,VEGFA |
GO:0009894 | regulation of catabolic process | 11 | 1038 | 0.49 | HGF,APOE,SORL1,DESI1,PML,IGF1,APOA2,ANGPTL3,INS,TNF,FGF21 |
GO:0035094 | response to nicotine | 3 | 50 | 1.24 | EDN1,AVP,TNF |
GO:0009895 | negative regulation of catabolic process | 6 | 316 | 0.74 | HGF,SORL1,PML,APOA2,INS,TNF |
GO:0010906 | regulation of glucose metabolic process | 4 | 118 | 1 | IGF1,C1QTNF3,INS,ADIPOQ |
GO:0034764 | positive regulation of transmembrane transport | 5 | 208 | 0.85 | CCL2,IGF1,INS,ADIPOQ,FGF21 |
GO:0042060 | wound healing | 7 | 439 | 0.67 | TGFB1,KLKB1,WNT3A,CD40LG,THBD,INS,VEGFA |
GO:0002703 | regulation of leukocyte mediated immunity | 5 | 209 | 0.84 | TGFB1,ICAM1,TLR4,ITGB2,TNF |
GO:0050830 | defense response to Gram-positive bacterium | 4 | 119 | 0.99 | CRP,IL6R,MBL2,TNF |
GO:0006909 | phagocytosis | 5 | 210 | 0.84 | CRP,PTX3,MBL2,TLR4,ITGB2 |
GO:0008203 | cholesterol metabolic process | 4 | 120 | 0.99 | APOE,CYP2D6,APOA2,ANGPTL3 |
GO:0001706 | endoderm formation | 3 | 52 | 1.23 | MMP14,DKK1,ITGB2 |
GO:0001878 | response to yeast | 2 | 11 | 1.73 | MPO,PTX3 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 4 | 121 | 0.98 | TGFB1,TLR4,ADIPOQ,TNF |
GO:0009612 | response to mechanical stimulus | 5 | 212 | 0.84 | MPO,CHI3L1,MMP14,TLR4,EDN1 |
GO:0032374 | regulation of cholesterol transport | 3 | 52 | 1.23 | APOE,APOA2,ADIPOQ |
GO:0042447 | hormone catabolic process | 2 | 11 | 1.73 | ACE,SPP1 |
GO:0043523 | regulation of neuron apoptotic process | 5 | 212 | 0.84 | CCL2,APOE,MTNR1B,NGF,TNF |
GO:0090193 | positive regulation of glomerulus development | 2 | 11 | 1.73 | IL6R,ADIPOQ |
GO:0006066 | alcohol metabolic process | 6 | 324 | 0.73 | APOE,IGF1,AKR1B10,CYP2D6,APOA2,ANGPTL3 |
GO:0002683 | negative regulation of immune system process | 7 | 450 | 0.66 | TGFB1,CCL2,APOA2,TLR4,INS,ADIPOQ,TNF |
GO:0042116 | macrophage activation | 3 | 53 | 1.22 | TLR4,ITGB2,TNF |
GO:0071417 | cellular response to organonitrogen compound | 8 | 590 | 0.6 | ICAM1,IGF1,TLR4,EDN1,INS,ADIPOQ,TNF,FGF21 |
GO:0030301 | cholesterol transport | 3 | 54 | 1.21 | APOE,LRP6,APOA2 |
GO:0002698 | negative regulation of immune effector process | 4 | 125 | 0.97 | TGFB1,APOA2,INS,TNF |
GO:0030879 | mammary gland development | 4 | 126 | 0.97 | LRP6,PML,WNT3A,VEGFA |
GO:0032944 | regulation of mononuclear cell proliferation | 5 | 220 | 0.82 | CRP,WNT3A,IGF1,CD40LG,TLR4 |
GO:0033700 | phospholipid efflux | 2 | 12 | 1.69 | APOE,APOA2 |
GO:0036499 | PERK-mediated unfolded protein response | 2 | 12 | 1.69 | CCL2,CXCL8 |
GO:0048672 | positive regulation of collateral sprouting | 2 | 12 | 1.69 | WNT3A,NGF |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2 | 12 | 1.69 | TLR4,TNF |
GO:0046503 | glycerolipid catabolic process | 3 | 56 | 1.19 | FABP4,PLA2G7,APOA2 |
GO:0060688 | regulation of morphogenesis of a branching structure | 3 | 56 | 1.19 | HGF,TNF,VEGFA |
GO:0002699 | positive regulation of immune effector process | 5 | 223 | 0.82 | TGFB1,TLR4,ITGB2,TNF,GPI |
GO:0055082 | cellular chemical homeostasis | 9 | 753 | 0.54 | APOE,MTNR1B,LRP6,ICAM1,PML,EDN1,AVP,C1QTNF3,FGF21 |
GO:0051604 | protein maturation | 5 | 225 | 0.81 | SORL1,KLKB1,ACE,MMP14,NGF |
GO:0002024 | diet induced thermogenesis | 2 | 13 | 1.65 | SORL1,UCP1 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 2 | 13 | 1.65 | CRP,ADIPOQ |
GO:0019430 | removal of superoxide radicals | 2 | 13 | 1.65 | MPO,SOD3 |
GO:0034380 | high-density lipoprotein particle assembly | 2 | 13 | 1.65 | APOE,APOA2 |
GO:0044793 | negative regulation by host of viral process | 2 | 13 | 1.65 | CRP,PTX3 |
GO:0050680 | negative regulation of epithelial cell proliferation | 4 | 131 | 0.95 | TGFB1,CCL2,APOE,TNF |
GO:0002090 | regulation of receptor internalization | 3 | 58 | 1.18 | WNT3A,DKK1,VEGFA |
GO:0045840 | positive regulation of mitotic nuclear division | 3 | 58 | 1.18 | IGF1,EDN1,INS |
GO:0050922 | negative regulation of chemotaxis | 3 | 58 | 1.18 | CCL2,SEMA3A,WNT3A |
GO:0050807 | regulation of synapse organization | 5 | 228 | 0.81 | APOE,WNT3A,DKK1,INS,TNF |
GO:0046887 | positive regulation of hormone secretion | 4 | 132 | 0.95 | EDN1,C1QTNF3,SPP1,INS |
GO:0097755 | positive regulation of blood vessel diameter | 3 | 59 | 1.17 | APOE,MTNR1B,INS |
GO:1903793 | positive regulation of anion transport | 3 | 59 | 1.17 | APOE,EDN1,AVP |
GO:0050671 | positive regulation of lymphocyte proliferation | 4 | 134 | 0.94 | WNT3A,IGF1,CD40LG,TLR4 |
GO:0015909 | long-chain fatty acid transport | 3 | 60 | 1.16 | APOE,FABP4,ACE |
GO:0032720 | negative regulation of tumor necrosis factor production | 3 | 60 | 1.16 | IGF1,TLR4,ADIPOQ |
GO:0035690 | cellular response to drug | 3 | 60 | 1.16 | EDN1,ADIPOQ,FGF21 |
GO:0045669 | positive regulation of osteoblast differentiation | 3 | 60 | 1.16 | HGF,IGF1,IL6R |
GO:0097305 | response to alcohol | 5 | 233 | 0.8 | TGFB1,LRP6,ICAM1,AVP,ADIPOQ |
GO:0003084 | positive regulation of systemic arterial blood pressure | 2 | 14 | 1.62 | ACE,AVP |
GO:0010870 | positive regulation of receptor biosynthetic process | 2 | 14 | 1.62 | EDN1,FGF21 |
GO:0010896 | regulation of triglyceride catabolic process | 2 | 14 | 1.62 | SORL1,FGF21 |
GO:0032375 | negative regulation of cholesterol transport | 2 | 14 | 1.62 | APOE,APOA2 |
GO:0044255 | cellular lipid metabolic process | 10 | 939 | 0.49 | APOE,FABP4,PLA2G7,AKR1B10,CYP2D6,APOA2,ANGPTL3,EDN1,ADIPOQ,C19orf80 |
GO:0051917 | regulation of fibrinolysis | 2 | 14 | 1.62 | KLKB1,THBD |
GO:0055114 | oxidation-reduction process | 10 | 939 | 0.49 | MPO,PLA2G7,AKR1B10,CYP2D6,APOA2,TXN,SOD3,ADIPOQ,GPI,ENO2 |
GO:0060429 | epithelium development | 11 | 1109 | 0.46 | TGFB1,LRP6,ICAM1,SEMA3A,PML,WNT3A,MMP14,DKK1,EDN1,LAMA1,VEGFA |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 4 | 136 | 0.93 | APOE,SORL1,LRP6,ADIPOQ |
GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA | 2 | 14 | 1.62 | TGFB1,TNF |
GO:0009620 | response to fungus | 3 | 61 | 1.16 | MPO,PTX3,TLR4 |
GO:0048844 | artery morphogenesis | 3 | 61 | 1.16 | APOE,ANGPTL3,VEGFA |
GO:0055081 | anion homeostasis | 3 | 61 | 1.16 | APOE,ANGPTL3,INS |
GO:0006469 | negative regulation of protein kinase activity | 5 | 236 | 0.79 | APOE,FABP4,SORL1,LRP6,ADIPOQ |
GO:0043312 | neutrophil degranulation | 7 | 484 | 0.63 | CEACAM6,MPO,CHI3L1,PTX3,LRG1,ITGB2,GPI |
GO:0043436 | oxoacid metabolic process | 10 | 944 | 0.49 | TGFB1,HGF,MPO,IGF1,CYP2D6,ANGPTL3,EDN1,ADIPOQ,GPI,ENO2 |
GO:0046888 | negative regulation of hormone secretion | 3 | 62 | 1.15 | MTNR1B,EDN1,ADIPOQ |
GO:0010638 | positive regulation of organelle organization | 8 | 633 | 0.57 | ICAM1,PML,IGF1,CTGF,EDN1,INS,TNF,VEGFA |
GO:0002449 | lymphocyte mediated immunity | 4 | 141 | 0.92 | CRP,ICAM1,CD40LG,MBL2 |
GO:0010935 | regulation of macrophage cytokine production | 2 | 15 | 1.59 | TGFB1,TLR4 |
GO:0015671 | oxygen transport | 2 | 15 | 1.59 | NGB,HBA1 |
GO:0033043 | regulation of organelle organization | 12 | 1306 | 0.43 | HGF,ICAM1,PML,WNT3A,IGF1,CTGF,EDN1,AVP,INS,TNF,ENO2,VEGFA |
GO:0050930 | induction of positive chemotaxis | 2 | 15 | 1.59 | CXCL8,VEGFA |
GO:1903140 | regulation of establishment of endothelial barrier | 2 | 15 | 1.59 | TNF,VEGFA |
GO:0032507 | maintenance of protein location in cell | 3 | 64 | 1.14 | SORL1,PML,TXN |
GO:0031644 | regulation of nervous system process | 4 | 144 | 0.91 | HGF,MTNR1B,EDN1,AVP |
GO:0001756 | somitogenesis | 3 | 66 | 1.12 | LRP6,WNT3A,DKK1 |
GO:0031349 | positive regulation of defense response | 6 | 367 | 0.68 | FABP4,KLKB1,PLA2G7,TLR4,MUC16,TNF |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 2 | 16 | 1.56 | CEACAM6,TNF |
GO:0045725 | positive regulation of glycogen biosynthetic process | 2 | 16 | 1.56 | IGF1,INS |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 2 | 16 | 1.56 | APOE,TNF |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 2 | 16 | 1.56 | CCL2,TLR4 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 3 | 66 | 1.12 | CCL2,DKK1,TNF |
GO:0055089 | fatty acid homeostasis | 2 | 16 | 1.56 | APOE,INS |
GO:0071637 | regulation of monocyte chemotactic protein-1 production | 2 | 16 | 1.56 | C1QTNF3,ADIPOQ |
GO:0006796 | phosphate-containing compound metabolic process | 16 | 2107 | 0.35 | TGFB1,HGF,CCL2,PML,PLA2G7,IGF1,MOK,APOA2,CD40LG,ANGPTL3,TLR4,AVP,LAMA1,TNF,GPI,ENO2 |
GO:0007267 | cell-cell signaling | 11 | 1145 | 0.45 | HGF,APOE,MTNR1B,LRP6,WNT3A,DKK1,EDN1,AVP,INS,ITGB2,FGF21 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 15 | 1906 | 0.36 | TGFB1,HGF,CCL2,APOE,LRP6,PML,WNT3A,IGF1,TLR4,EDN1,SPP1,INS,TNF,FGF21,VEGFA |
GO:0031334 | positive regulation of protein-containing complex assembly | 5 | 249 | 0.77 | TGFB1,ICAM1,TLR4,TNF,VEGFA |
GO:0098609 | cell-cell adhesion | 7 | 505 | 0.61 | CEACAM6,LRP6,ICAM1,WNT3A,CD40LG,ITGB2,TNF |
GO:0043524 | negative regulation of neuron apoptotic process | 4 | 148 | 0.9 | CCL2,APOE,MTNR1B,NGF |
GO:0044237 | cellular metabolic process | 38 | 7513 | 0.17 | TGFB1,HGF,MPO,CCL2,APOE,FABP4,SORL1,DESI1,PML,PLA2G7,ACE,ALB,IGF1,CXCL8,NAGPA,HBA1,AKR1B10,CYP2D6,MOK,CTGF,APOA2,NGF,CD40LG,ANGPTL3,TLR4,EDN1,AVP,SOD3,LAMA1,SPP1,INS,ITGB2,MUC16,ADIPOQ,TNF,GPI,ENO2,C19orf80 |
GO:1902532 | negative regulation of intracellular signal transduction | 7 | 508 | 0.6 | APOE,MTNR1B,SORL1,TLR4,C1QTNF3,INS,ADIPOQ |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 3 | 68 | 1.11 | IGF1,IL6R,TNF |
GO:0006641 | triglyceride metabolic process | 3 | 69 | 1.1 | APOE,FABP4,APOA2 |
GO:0043691 | reverse cholesterol transport | 2 | 17 | 1.54 | APOE,APOA2 |
GO:0046579 | positive regulation of Ras protein signal transduction | 3 | 69 | 1.1 | EPOR,IGF1,NGF |
GO:0060445 | branching involved in salivary gland morphogenesis | 2 | 17 | 1.54 | SEMA3A,LAMA1 |
GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade | 2 | 17 | 1.54 | IGF1,TNF |
GO:0090336 | positive regulation of brown fat cell differentiation | 2 | 17 | 1.54 | FNDC5,INS |
GO:1900221 | regulation of amyloid-beta clearance | 2 | 17 | 1.54 | APOE,TNF |
GO:1903206 | negative regulation of hydrogen peroxide-induced cell death | 2 | 17 | 1.54 | HGF,TXN |
GO:0045666 | positive regulation of neuron differentiation | 6 | 377 | 0.67 | HGF,APOE,WNT3A,NGF,DKK1,VEGFA |
GO:0008202 | steroid metabolic process | 5 | 256 | 0.76 | APOE,CYP2D6,APOA2,ANGPTL3,SPP1 |
GO:0032787 | monocarboxylic acid metabolic process | 7 | 515 | 0.6 | IGF1,CYP2D6,ANGPTL3,EDN1,ADIPOQ,GPI,ENO2 |
GO:0001837 | epithelial to mesenchymal transition | 3 | 70 | 1.1 | TGFB1,HGF,LRP6 |
GO:0050771 | negative regulation of axonogenesis | 3 | 70 | 1.1 | SEMA3A,WNT3A,SPP1 |
GO:0008360 | regulation of cell shape | 4 | 153 | 0.88 | CCL2,ICAM1,ITGB2,VEGFA |
GO:1903900 | regulation of viral life cycle | 4 | 153 | 0.88 | PML,PTX3,CXCL8,TNF |
GO:0007548 | sex differentiation | 5 | 259 | 0.75 | LRP6,ICAM1,PTX3,MMP14,VEGFA |
GO:0050795 | regulation of behavior | 3 | 71 | 1.09 | APOE,MTNR1B,INS |
GO:0031065 | positive regulation of histone deacetylation | 2 | 18 | 1.51 | PML,VEGFA |
GO:0034249 | negative regulation of cellular amide metabolic process | 4 | 154 | 0.88 | APOE,SORL1,PML,IGF1 |
GO:0043116 | negative regulation of vascular permeability | 2 | 18 | 1.51 | APOE,VEGFA |
GO:0050777 | negative regulation of immune response | 4 | 154 | 0.88 | TGFB1,APOA2,INS,TNF |
GO:0048699 | generation of neurons | 13 | 1551 | 0.39 | TGFB1,HGF,APOE,SORL1,LRP6,SEMA3A,WNT3A,NGF,DKK1,LAMA1,SPP1,TNF,VEGFA |
GO:0048863 | stem cell differentiation | 4 | 156 | 0.87 | LRP6,SEMA3A,ACE,EDN1 |
GO:0007399 | nervous system development | 17 | 2371 | 0.32 | TGFB1,EPOR,HGF,CCL2,APOE,SORL1,LRP6,SEMA3A,WNT3A,MMP14,NGF,DKK1,TLR4,LAMA1,SPP1,TNF,VEGFA |
GO:0045787 | positive regulation of cell cycle | 6 | 388 | 0.65 | LRP6,PML,IGF1,CTGF,EDN1,INS |
GO:0048589 | developmental growth | 6 | 389 | 0.65 | LRP6,SEMA3A,WNT3A,PTX3,IGF1,MBL2 |
GO:0001816 | cytokine production | 4 | 158 | 0.87 | CHI3L1,FABP4,TLR4,TNF |
GO:0016485 | protein processing | 4 | 158 | 0.87 | KLKB1,ACE,MMP14,NGF |
GO:0010544 | negative regulation of platelet activation | 2 | 19 | 1.49 | APOE,THBD |
GO:0030593 | neutrophil chemotaxis | 3 | 74 | 1.07 | CCL2,CXCL8,ITGB2 |
GO:0031346 | positive regulation of cell projection organization | 6 | 391 | 0.65 | HGF,APOE,WNT3A,NGF,INS,VEGFA |
GO:0043627 | response to estrogen | 3 | 74 | 1.07 | TNFRSF11B,MMP14,APOA2 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 2 | 19 | 1.49 | ITGB2,FGF21 |
GO:0044238 | primary metabolic process | 37 | 7332 | 0.17 | TGFB1,HGF,CCL2,APOE,CHI3L1,FABP4,SORL1,DESI1,KLKB1,PML,PLA2G7,ACE,ALB,ANGPTL4,IGF1,MMP14,NAGPA,AKR1B10,CYP2D6,MOK,CTGF,APOA2,NGF,CD40LG,ANGPTL3,TLR4,EDN1,AVP,LAMA1,SPP1,INS,MUC16,ADIPOQ,TNF,GPI,ENO2,C19orf80 |
GO:0033157 | regulation of intracellular protein transport | 5 | 268 | 0.74 | TGFB1,SORL1,TXN,ITGB2,ADIPOQ |
GO:0043407 | negative regulation of MAP kinase activity | 3 | 76 | 1.06 | APOE,SORL1,ADIPOQ |
GO:0006622 | protein targeting to lysosome | 2 | 20 | 1.47 | SORL1,NAGPA |
GO:0010875 | positive regulation of cholesterol efflux | 2 | 20 | 1.47 | APOE,ADIPOQ |
GO:0019752 | carboxylic acid metabolic process | 9 | 853 | 0.49 | TGFB1,HGF,IGF1,CYP2D6,ANGPTL3,EDN1,ADIPOQ,GPI,ENO2 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2 | 20 | 1.47 | TLR4,ITGB2 |
GO:1900409 | positive regulation of cellular response to oxidative stress | 2 | 20 | 1.47 | TLR4,TNF |
GO:1902004 | positive regulation of amyloid-beta formation | 2 | 20 | 1.47 | APOE,TNF |
GO:2000353 | positive regulation of endothelial cell apoptotic process | 2 | 20 | 1.47 | CCL2,CD40LG |
GO:1901564 | organonitrogen compound metabolic process | 29 | 5244 | 0.21 | TGFB1,HGF,CCL2,APOE,CHI3L1,SORL1,DESI1,KLKB1,PML,PLA2G7,ACE,ALB,IGF1,MMP14,NAGPA,CYP2D6,MOK,APOA2,NGF,CD40LG,TLR4,AVP,LAMA1,SPP1,INS,MUC16,TNF,GPI,ENO2 |
HSA-8963899 | Plasma lipoprotein remodeling | 7 | 32 | 1.81 | APOE,ALB,ANGPTL4,APOA2,ANGPTL3,FGF21,C19orf80 |
HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 9 | 107 | 1.39 | TGFB1,HGF,CCL2,ICAM1,CXCL8,IL6R,ITGB2,TNF,VEGFA |
HSA-168256 | Immune System | 23 | 1956 | 0.54 | CEACAM6,TGFB1,HGF,MPO,CCL2,CRP,CHI3L1,ICAM1,PML,PTX3,TNFRSF11B,LRG1,CXCL8,IL6R,CD40LG,MBL2,TLR4,TXN,ITGB2,MUC16,TNF,GPI,VEGFA |
HSA-8963889 | Assembly of active LPL and LIPC lipase complexes | 4 | 19 | 1.79 | ANGPTL4,ANGPTL3,FGF21,C19orf80 |
HSA-1280215 | Cytokine Signaling in Immune system | 12 | 681 | 0.71 | TGFB1,HGF,CCL2,ICAM1,PML,TNFRSF11B,CXCL8,IL6R,CD40LG,ITGB2,TNF,VEGFA |
HSA-162582 | Signal Transduction | 24 | 2741 | 0.41 | TGFB1,EPOR,HGF,CCL2,APOE,MTNR1B,LRP6,PML,WNT3A,IGF1,CXCL8,AKR1B10,APOA2,IL6R,NGF,ANGPTL3,DKK1,EDN1,AVP,LAMA1,SPP1,INS,TNF,VEGFA |
HSA-1474244 | Extracellular matrix organization | 8 | 301 | 0.89 | CEACAM6,TGFB1,KLKB1,ICAM1,MMP14,LAMA1,SPP1,ITGB2 |
HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 5 | 84 | 1.24 | TGFB1,FABP4,ANGPTL4,ADIPOQ,TNF |
HSA-6783783 | Interleukin-10 signaling | 4 | 45 | 1.41 | CCL2,ICAM1,CXCL8,TNF |
HSA-3772470 | Negative regulation of TCF-dependent signaling by WNT ligand antagonists | 3 | 15 | 1.77 | LRP6,WNT3A,DKK1 |
HSA-382551 | Transport of small molecules | 11 | 721 | 0.65 | APOE,LCN9,ALB,NGB,ANGPTL4,HBA1,APOA2,ANGPTL3,AVP,FGF21,C19orf80 |